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13 INTRODUCTION 
1 INTRODUCTION 
1.1 RADIATION 
1.1.1 OVERVIEW OF RADIATION-FORMS 
Radiation is defined as a process of energy emission in the form of particles or waves. It can 
be categorized into two forms: ionizing radiation (IR) and non-ionizing radiation. IR holds 
high energy and has the capability to remove tightly bound electrons from atoms. It comprises 
subatomic particles, ions or atoms and also electromagnetic waves positioned on the short 
wavelength end of the electromagnetic spectrum. Alpha and beta particles as well as neutrons 
are typical particles, whereas gamma rays and X-rays are ionizing electromagnetic waves. 
Non-ionizing radiation is inadequate to remove tightly bound electrons from atoms, and it is 
mainly used for common purpose, for instance as infrared, microwaves, or radio waves (Ng 
2003). 
The use of high-energy IR to treat cancer is known as radiation therapy. For more than 
100 years, IR has been used as the standard clinical treatment to cure different cancers in 
humans. Today, radiation therapy remains to be one of the most common respective 
treatments: around half of all cancer patients worldwide receive radiation therapy either alone 
or in combination with surgery or chemotherapy (Baskar et al 2012). Radiation therapy is 
delivered to patients in two different ways: internally or externally. Internal radiation therapy 
refers to a radioactive source like radioactive seeds being applied to the body. External 
radiation therapy is applied through a machine that delivers high-energy X-rays to the cancer 
(Kaliberov and Buchsbaum 2012). 
          Radiation therapy can harm cancer cells or can kill those cells using waves or high-
energy particles. Radiation exerts two types of effects upon exposure to cells, namely a direct 
and an indirect effect. When radiation directly interacts with deoxyribonucleic acid (DNA), 
the bonds between the atoms can break or some other important components of cell playing a 
vital role in cell survival can be damage. This kind of effect might lead to a failure of cell 
reproducibility and can also cause damage in chromosomes to replicate properly (Morgan 
and Sowa 2005) (see Figure 1). On the other hand, indirect radiation effects are caused when 
radiation interacts with water molecules. The water molecule inside the cells are ionized and 
free radicals are produced which are highly reactive molecules. These free radicals can break 
the bonds between cell components including DNA and thus cause cell destruction (Lewanski 
and Gullick 2001) (see Figure 1).  
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Figure 1: Direct and indirect effects of radiation. Different cellular cell components or 
atoms of DNA molecules can be affected directly by radiation (direct effect; upper part), 
whereas radiation may also activate water molecules (indirect effect; lower part). The latter 
effect results in breaking the bonds between the water molecules and the production of free 
radicals. Adapted from (Morgan and Sowa 2005). 
 
Even though radiation therapy is considered to be one of the important treatments for curing 
cancer, it also remains a curse by harming normal cells with some side effects. Nevertheless, 
radiation therapy holds a huge potential promise for further cancer treatments (Thariat et al 
2013). 
 
1.1.2 TYPES OF RADIATION-INDUCED APOPTOTIC CELL DEATH 
Exposure to IR results in a variety of malfunctions like damage of DNA resulting in DNA 
double strand breaks. This damage of DNA is found to be dose-dependent (Chang et al 1999, 
Haines et al 2002). Both high and low IR doses are able to cause adverse effects depending on 
the sensitivity of the cells. Radiation is known to target cells by depositing the energy directly 
on them but it was shown that even the cells that have never been directly exposed to 
irradiation are impaired because of the radiation dose applied to neighboring cells. This kind 
of effect is termed as the “bystander effect” (Prise et al 2003, Suzuki and Yamashita 2014, 
Ward 2002) and is able to induce apoptosis (programmed cell death) (Belyakov et al 2002) in 
unaffected cells or can also cause transformation processes in proteins associated with 
apoptosis (Vines et al 2009).  
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IR mediates cell death in two different ways, early (1.1.2.1) and late cell death (1.1.2.2). 
These two types of cell death are distinguished by two factors: firstly by the amount of time 
taken by cells to undergo apoptosis, and secondly by the characteristic biochemical changes 
observed in the cells (Shinomiya 2001). Furthermore, depending on the cell type, the 
mechanism of IR-induced cell death can vary (Joiner and van der Kogel 2009). It has been 
reported that under modulated changes in the IR doses, the same cells can exhibit both types 
of cell death. For example: compared to an IR dose of 20 Gy, where early cell death (within 4 
to 6 h) could be observed with a vigorous apoptosis on the other hand radiation dose up to 5 
Gy induced a late cell death (after 24 h or later) with moderate apoptosis in a U937 human 
monoblastoid cell line (Shinomiya et al 2000). Similar results were obtained in human 
leukemia cell lines (MOLT-4; HL-60) demonstrating that these particular cell lines were able 
to undergo both types of cell death upon IR, depending on different radiation doses 
(Mareková et al 2003, Shinohara and Nakano 1993). 
 
1.1.2.1 Early cell death: pre-mitotic apoptosis 
Early or pre-mitotic cell death is caused when cell death occurs before the mitosis. It is known 
to occur in certain or rather specific cell types (Kondo 2013, Shinomiya et al 2000). It is also 
known as interphase death. The affected cells undergo shrinkage, condensation, pyknosis and 
disruption of DNA (Shinomiya 2001, Yamada and Ohyama 1988). Early cell death occurs by 
irradiation-caused damage at cellular levels leading to an activation of various pathways for 
example the p53-pathway activated after IR-induced DNA double strand breaks ultimately 
resulting in cell death. Cells are, vice versa, no longer able to undergo early cell death when 
they bear a defect in the respective p53 gene (Joiner and van der Kogel 2009). 
 
1.1.2.2 Late cell death: post-mitotic apoptosis 
When cells pursuit mitosis and cell death occurs after a long period of time upon irradiation it 
is termed as late cell death or post-mitotic. This type of cell death is also named reproductive 
cell death, as the cells stop dividing. Affected cells lose their potential to form colonies, the 
hallmark of late cell death (Forrester et al 1999, Shinomiya 2001). Within some minutes after 
irradiation DNA damage response (DDR) is activated leading to activation of p53 and thus 
resulting in stimulation of various pro-apoptotic proteins (Sakaguchi et al 1998). On the other 
hand cell-cycle checkpoints and DNA repair systems are also activated by the DDR (Zhou 
and Elledge 2000). Even though provocation of pro-survival pathway is initiated by DDR, the 
  
16 INTRODUCTION 
cells still prolong in the phase of apoptosis because of the initial deterioration affect in cells 
upon irradiation (Joiner and van der Kogel 2009). 
1.1.3 RADIORESISTANCE AND CANCER CELLS 
Radioresistant tumor cells are the results of certain factors (Peters et al 1982); however, the 
major reason still needs to be characterized. Even though a lot of efforts are undertaken to 
overcome a possible resistance of tumor cells towards radiation therapy however failure to 
this process has often been recorded. Most cancer cells can overcome the fractionated doses 
of irradiation and become radioresistant (Li et al 2014), but there are some cancer cell types 
showing inherited radioresistant capacities (Weichselbaum et al 1985).     
A number of factors possibly promote cancer cells to become radioresistant. Some genes have 
been identified to modulate the radiation response of some cancer cells, being regulated up 
and down shown particularly in radioresistant pancreatic cancer cell lines. Genes that were 
found to be up-regulated were associated with amphiregulin, mitogen-activated protein 
kinase-activated protein kinase 2 (MAPKAPK2), regucalcin, and angiopoietin 2 and the 
down-regulated genes were related with caspase 8, retinoid esterification (lecithin retinol 
acyltransferase), and calcium-activated chloride channel 1 (Ogawa et al 2006). Further studies 
on the functional pathways of these up- and down-regulated genes might provide a beneficial 
strategy to better understand and react to radioresistance of cancer cells. 
Among all radioresistant tumors, certain types of glioblastoma (glioblastoma multiforme) 
remain a special challenge. Glioblastomas which arise from astrocytes belong to the 
malignant glioma forms (Facchino et al 2011). Even though the treatment of glioblastomas 
with radiotherapy was found to be potent, it still remains ultimately lethal (Zhou et al 2013) 
because of the tumor reoccurrence in most cases (Nagashima et al 1989).  
Gliomas are known to overcome radiation treatment by various mechanisms one of which is 
their capacity for repairing DNA (Bao et al 2006). Particularly, it has been shown that, in 
comparison to normal human astrocytes, glioma cells exhibit higher expression of γH2AX 
and Rad51 (DNA repair proteins) upon irradiation, which are the most important proteins in 
the process of regulating DNA repair (Short et al 2007). Another player in radioresistance of 
glioma stem cells are the Notch proteins, the critical factors for providing resistance to 
gliomas upon irradiation. The down-regulation of Notch-1 and 2 resulted in loss of 
radioresistancy by sensitizing the cells towards irradiation (Wang et al 2010). Another factor 
that might strongly cause radioresistance of gliomas is hypoxia. It is known that tumor cells 
have significantly less oxygen content compared to normal cells, and the hypoxic conditions 
has a great impact on the expansion of tumors (Amberger-Murphy 2009). A further 
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intermediate reported to promote the radioresistance of glioblastoma is the 
phosphatidylinositol-4,5-bisphosphate 3-kinase-Akt (PI3K-Akt). The activation of PI3K-Akt 
induces an increase in radioresistance of glioblastoma cells, whereas the use of PI3K-Akt 
inhibitors or their inhibition at the genetic level carries the potential to abolish this effect (Li 
et al 2009). 
1.2 REACTIVE OXYGEN SPECIES (ROS) 
Reactive oxygen species (ROS), also known as oxygen radicals, are molecules derived from 
oxygen which are chemically active (Rada and Leto 2008). They are known to originate 
endogenously in the human body and play an important role in the pathophysiology of various 
diseases (Alfadda and Sallam 2012, Devasagayam et al 2004). Several categories of ROS are 
known to be generated in particular alkoxyl (RO·), hydrogen peroxide (H2O2), hydroxyl 
radicals (·OH), nitrogen dioxide (·NO2), nitric oxide (·NO) peroxynitrite (ONOO−) and 
superoxide anions (O2·−) (Finkel and Holbrook 2000). Cellular molecules like DNA (Luo et al 
2013), lipids (El-Aal 2012) and proteins (Stadtman 1990, Stadtman and Levine 2000) can be 
harmed by the production of ROS. A damage of these macromolecules through oxidative 
stress leads to changes involved in a variety of human diseases including acute myeloid 
leukemia (AML) (Ghoti et al 2007, Novotna et al 2009, Zhou et al 2010), atherosclerosis 
(Ding et al 2013), bone related disorders (Ha et al 2004, Kanzaki et al 2013, Lean et al 2005, 
Lee et al 2005b, Srinivasan et al 2010), diabetes (Babizhayev et al 2014), fibrotic disease 
(Sampson et al 2012), neurological disorders (Okado-Matsumoto and Fridovich 2002, 
Palacino et al 2004, Shimoda-Matsubayashi et al 1996) and obesity (Calzadilla et al 2011, 
Furukawa et al 2004) etc. Recently it has been reported that ROS can act as an important 
target during cancer progression, showing ROS co-ordinates with other regulators like p53 in 
mediating cell death (Ribas et al 2015). ROS is also known to be an intermediate of various 
signaling pathways: protein kinase B /mechanistic target of rapamycin (Akt/mTOR) pathway 
(Cai and Andres 2014, Cao et al 2009, Fiorini et al 2015), extracellular-signal-regulated 
kinases (ERK) and activator protein-1 (AP-1) signaling (Czaja et al 2003), c-Jun N-terminal 
kinases (JNK/c-Jun) signaling pathway (Amir et al 2012, Singh et al 2009), mitogen-
activated protein kinases (MAPK) activation (Olavarria et al 2015) and nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-kappaB) (Natarajan et al 2002, Storz and Toker 
2003, Volanti et al 2002). 
Various sources of ROS production have been reported: cyclooxygenase (Beak et al 2004), 
lipoxygenase (Mascayano et al 2014), mitochondrial electron transport enzymes (Lambert and 
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Brand 2009), nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase) 
(Paravicini and Touyz 2008), nitric oxide synthase (Vasquez-Vivar and Kalyanaraman 2000) 
and xanthine oxidase (Pritsos 2000). Both mitochondrial and NADPH oxidase ROS are the 
most studied means of ROS production. 
1.2.1 MITOCHONDRIAL ROS PRODUCTION 
Mitochondria are considered to be the most important sources of ROS production. Superoxide 
anions (O2·−) are the best studied and understood ROS produced by mitochondria in 
mammals. The production of mitochondrial ROS is regulated by the oxidative 
phosphorylation (OXPHOS) process in the inner mitochondrial membrane through the 
electron transport chain (ETC). OXPHOS involves the formation of adenosine triphosphate 
(ATP) by using oxygen in the ETC. The latter contains various complexes namely: complex I 
(Nicotinamide adenine dinucleotide (NADH) dehydrogenase), complex II (succinate 
dehydrogenase), complex III (ubiquinol-cytochrome c reductase), complex IV (cytochrome c 
oxidase) and complex V (Adenosine triphosphate (ATP) synthase). In the ETC, a diffusion of 
electrons from complex I and III leads to a reduction of oxygen producing superoxide (Li et al 
2013a, Murphy 2009) (see Figure 1.2.1). 
Mitochondrial ROS is involved in a variety of diseases including amyotrophic lateral sclerosis 
(ALS) (Okado-Matsumoto and Fridovich 2002), atherosclerosis (Ding et al 2013), heart 
failure (Schwarzer et al 2014), ischaemia-reperfusion injury (Liang et al 2013) and 
Parkinson's disease (Palacino et al 2004, Shimoda-Matsubayashi et al 1996). Also, its 
involvement during the ageing process (Ames et al 1995, Terman et al 2010) and in tumor 
angiogenesis has been reported (Zhou and Ryeom 2014). 
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Figure 1.2.1: Superoxide is generated within the mitochondrial matrix and inner 
mitochondrial membrane. The complexes I and III of the ETC are the major sources of its 
production. However, 2-oxoglutarate dehydrogenase (OGDH), pyruvate dehydrogenase 
(PDH), glycerol 3-phosphate dehydrogenase (GPDH) and also the electron transfer 
flavoprotein-ubiquinone oxidoreductase (FQR) are additional sources for generating 
superoxide in mitochondria (Holmstrom and Finkel 2014). 
 
1.2.2 NADPH OXIDASE SYSTEM AS A SOURCE OF ROS PRODUCTION 
In addition to mitochondria, other sources for ROS production in a variety of cell lines has 
been identified, one of them include NADPH oxidase (NOX) (Weyemi and Dupuy 2012). 
NOX is known to be a strong regulator of ROS generation in phagocytic cells in mammals 
(Orient et al 2007). It is a membrane-bound enzyme and drives the release of superoxide from 
oxygen and NADPH. It is the complex assembled by components containing: the membrane 
subunits (gp91phox and p22phox) and the cytosolic subunits (p40phox, p47phox, p67phox, 
and two guanine nucleotide-binding proteins: guanosine triphosphate (GTP) Rac-1 and Rac-2) 
(Assari 2006). Upon various stress stimuli, phosphorylation of the cytosolic component 
p47phox takes place and results in a complete translocation of cytosolic proteins to the cell 
membrane. This process leads to activation and assembly of both the membrane and the 
cytosolic subunit forming a complete NOX complex (Figure 1.2.2). Rac-1 and Rac-2 play a 
pivotal role during cytosolic translocation and complex formation (Babior 1999, Dang et al 
1999).  
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Figure 1.2.2: NOX comprises membrane subunits and cytosolic subunits. The membrane 
subunits consist of p22phox and gp91phox, and the cytosolic subunits consists of p40phox, 
p47phox, p67phox, and GTP binding proteins. Upon cell activation, the cytosolic subunits 
translocate to the cell membrane forming a complete NADPH oxidase complex, further 
resulting in ROS generation (Assari 2006). 
 
NOX seems to play a vital role in various diseases including Alzheimer’s disease 
(Shimohama et al 2000, Zekry et al 2003), atherosclerosis (Sorescu et al 2002), diabetes 
(Kowluru and Kowluru 2014, Padgett et al 2015), kidney disease (Thallas-Bonke et al 2014) 
and Parkinson disease (Zhang et al 2014) etc.  
 
1.3 CERAMIDE AND CERAMIDE-ENRICHED MEMBRANE PLAT-
FORMS 
1.3.1 MEMBRANE RAFTS AND PLATFORMS 
On the basis of thermodynamics, both structure and organization of lipids and proteins in cell 
plasma membranes were described through a model termed as fluid mosaic model (Singer and 
Nicolson 1972). Within the plasma membrane, lipid interaction appears weaker and short-
termed when compared to protein-protein interactions (Harder and Simons 1997). High 
concentration of proteins in cell membranes can, however, affect the lipid-lipid organization 
(Garcia-Saez and Schwille 2010). The plasma membrane constitutes of several different 
lipids, namely glycerophospholipids, sphingolipids and cholesterol.  
Several studies have suggested existence of a distinct membrane domains existing in a liquid-
ordered phase. These domains are composed of sphingolipid and cholesterol. Sphingomyelin 
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which is the prevalent cellular sphingolipid in the membrane is composed of a hydrophobic 
ceramide moiety and a hydrophilic phosphorylcholine head group. Sphingolipids are known 
to associate with each other via hydrophilic interactions and cholesterol via hydrophobic van 
der Waal interactions or hydrogen bonds (Brown and London 1998, Harder and Simons 1997, 
Simons and Ikonen 1997). Cholesterol is known to fill the voids between sphingolipids and 
stabilizes these domains (Simons and Ikonen 1997, Xu et al 2001). These interaction between 
lipids results in lateral separation of sphingolipids and cholesterol which results in the 
formation of sphingolipid and cholesterol-enriched membrane domains (Brown and London 
1998, Simons and Ikonen 1997) which are termed as membrane rafts. Because of the strong 
interaction between cholesterol with sphingolipids and the tight packing of acyl chains 
sphingolipids, phase separations within the membrane occurs resulting in a liquid-ordered 
phase (Brown and London 2000). On the other hand phospholipids with unsaturated acyl 
chains interact very weakly with cholesterol which results in liquid-disordered phase (Brown 
and London 2000, Brown 2006). 
Two types of proteins within the lipid rafts have been identified to date: firstly those which 
contain caveolins with their further subtypes caveolin-1, 2, and 3 (Ostrom and Insel 2006) and 
secondly those containing flotillins with their further subtypes flotillin-1 and 2 (Volonte et al 
1999). Caveolins and flotillins are plasma membrane proteins found in mammals (Parolini et 
al 1996, Salzer and Prohaska 2001). They are involved in a variety of cell functions like cell 
signaling, cell trafficking and cell signal transduction process (Alonso and Millan 2001, 
Simons and Toomre 2000). They are also known to play a role in various diseases including 
cancer (Cohen et al 2004). More specifically, the role of caveolin-1 has been reported clearly 
with its participation in promoting metastasis and tumor growth progression by suppression of 
apoptosis (Ho et al 2002, Ito et al 2002, Kato et al 2002, Shatz and Liscovitch 2008, Suzuoki 
et al 2002, Thompson et al 2010, Yang et al 1998).   
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Figure 1.3.1 Structure of lipid rafts. Lipid rafts are composed of phospholipids with 
unsaturated fatty acyl chains (in dark blue) and saturated fatty acyl chains (in brown) plus 
cholesterol (in yellow). The distribution of phospholipids and cholesterol in the cell plasma 
membrane can be observed in the intracellular as well as in the extracellular compartment. 
However, sphingolipids (in purple) exist mainly in the external part. Various proteins are 
concentrated in a lipid raft: transmembrane proteins (light blue), 
glycosylphosphatidylinositol-anchored proteins (orange), dually acylated proteins (in green) 
and prenylated protein (in pink) (Waheed and Freed 2009). (GPI 
glycosylphosphatidylinositol; GPLs glycerophospholipids; GSLs glycosphingolipids; SM 
sphingomyelin) 
 
Ceramide, a bio-active sphingolipid, plays a specific and important role in regulating the lipid 
rafts (Cremesti et al 2002). Ceramide-rich "domains" are known to be in a highly ordered 
state in comparison to cholesterol-containing rafts. Furthermore, ceramide shows the tendency 
to dislocate cholesterol from rafts which can cause a distinct property change in raft 
composition (Megha and London 2004, Yu et al 2005). 
1.3.2 CERAMIDE STRUCTURE AND GENERATION 
Ceramide is composed of a sphingosine joined with an amide bond to fatty acyl chains 
(Figure 1.3.2 a). Ceramide has been previously believed to be an entirely structural element 
found in the cell plasma membrane, but by now, its involvement in a variety of signaling 
pathways has been made clear (Chalfant et al 2002, Gulbins et al 1995, Hsieh et al 2014, 
Huwiler et al 1996, Kashiwagi et al 2002a, Yabu et al 2015, Zhang et al 1997). 
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Figure 1.3.2 (a): Structure of ceramide. Ceramide consists of a long chain base which is 
linked to a fatty acid via an amide bond. Adapted from (Mencarelli and Martinez-Martinez 
2013). 
 
Two pathways are known to be involved in the generation of sphingolipids/ceramide (Figure 
1.3.2 b).  
1. The sphingomyelin hydrolysis pathway proceeds with the hydrolysis of sphingomyelin 
by activation of the enzyme sphingomylinases (SMases) resulting in the formation of 
ceramide and phosphorylcholine. Three different types of sphingomylinases (SMases) 
have been identified on the basis of their pH-optimum: acidic SMases, neutral 
SMases, and alkaline SMases. They are known to be localized in different 
compartments within the cells (Fensome et al 2000, Hofmann et al 2000, Rajagopalan 
et al 2015, Spence et al 1983, Stoffel 1999, Tomiuk et al 2000, Wu et al 2010, Wu et 
al 2005). 
2. The de novo pathway involves merging of serine and palmitate-CoA giving rise to 3-
ketosphinganine which contains 18 carbon. The reaction is catalyzed by the enzyme 
serine palmitoyltransferase (SPT). Further, 3-ketosphinganine is reduced by the 
enzyme 3-ketosphinganine reductase (KDS) producing sphinganine. The next 
reaction continues with the production of di-hydro-ceramide (dhCer) by the enzyme 
ceramide synthase (CerS) (Mathias et al 1998, Michel et al 1997). CerS consists of a 
family of six enzymes with each of them showing a preference towards the acyl CoA 
chain length (Pewzner-Jung et al 2006, Saddoughi et al 2008). Based on its 
resemblance with the yeast longevity assurance gene 1 protein (LAG1p), CerS has 
been named as Lass (Longevity Assurance) genes (Riebeling et al 2003, 
Venkataraman et al 2002). Thus, CerS is an important enzyme for ceramide 
generation. Finally, in the presence of the enzyme dihydro-ceramide (dhCer) 
desaturase (DES), dhCer which lacks 4, 5-trans-double bond is desaturated producing 
ceramide with 4, 5-trans-double bond. This pathway takes place within the 
endoplasmic reticulum (ER). The generated ceramide is then carried to the Golgi 
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apparatus by help of ceramide transporter proteins (Kawano et al 2006) or by 
vesicular or non-vesicular processing (Funato and Riezman 2001) (Figure 1.3.2 b). 
 
Once ceramide is formed, it can be utilized by ceramidases (CDases) to produce sphingosine 
(Sph), which is phosphorylated to sphingosine-1-phosphate (S1P) by sphingosine kinases 
(SK) (Kohama et al 1998, Liu et al 2000). S1P can also be dephosphorylated by the action of 
enzyme SPPase (Sph phosphate phosphatase) to generate Sph (Mandala 2001, Mao and 
Obeid 2008). Ceramide can be phosphorylated by ceramide kinase (CK) which is then 
recycled by a ceramide-1-phosphate (C1P) phosphatase (C1PP) (Shinghal et al 1993) and 
further glycosylated to glucosylceramide (GC) and galactosylceramide (GalC) by the action 
of glucosylceramide synthase (GCS) or galactosylceramide synthase (GalCS) respectively. 
GC once formed can be translocated to leaflets from the late Golgi compartment with the 
involvement of four-phosphate adaptor proteins (FAPP2) (D'Angelo et al 2007). GC can be 
further processed and metabolized into complex glycosphingolipids which is essential for 
cell development and differentiation (Pescio et al 2012, Yamashita et al 1999). Ceramide 
glycosylated to GalC can be sulfated to form sulfatide. 
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Figure 1.3.2 (b): Sphingolipid/Ceramide metabolism. The sphingomyelin hydrolysis 
pathway generates ceramide via actions of acid or neutral SMase. Both enzymes break down 
sphingomyelin giving rise to ceramide and phosphorylcholine. The de novo pathway is 
regulated by the enzyme serine palmitoyltransferase involving various other enzymes (Bartke 
and Hannun 2009). (SPT serine palmitoyltransferase; KDS 3-keto-dihydrosphingosine 
reductase; DES dihydroceramide desaturase; SPPase Sph phosphate phosphatase; CK 
Ceramide kinase; C1PP C1P phosphatase; SMS SM synthase; PC phosphatidylcholine; DAG 
diacylglycerol; GCS glucosylceramide synthase; GCase glucosyl CDase) 
 
Among various sphingolipids, ceramide is known to be involved in different cell functions. It 
is certainly considered to be an important component for inducing apoptosis; it also 
participates in cancer cell death, differentiation and senescence (Karahatay et al 2007, 
Koybasi et al 2004, Ogretmen and Hannun 2004, Senkal et al 2007).  
Ceramide is known to be involved in cell signaling pathways by interacting with varieties of 
targets. It activates the kinase suppressor of RAS (KSR) (Zhang et al 1997). In intestinal 
epithelial cells, KSR is involved in the activation of extracellular-signal-regulated 
kinases (ERKs) ERK1/ERK2 mediated by ceramide (Yan and Polk 2001). If B-cell 
lymphoma 2 (Bcl-2)-antagonist of cell death (BAD), a pro-apoptotic member of the Bcl-2 
family are absent, KSR stimulates pro-inflammatory response (Basu et al 1998, Kolesnick and 
Kronke 1998). Ceramide also interacts with c-Raf kinase and has been shown to increase its 
activity by selectively binding to it, resulting in a provocation of mitogen-activated protein 
kinases (MAPK) signaling process (Huwiler et al 1996). Along with kinases, ceramide also 
interacts with various other proteins like protein phosphatases called ceramide-activated 
protein phosphatases (CAPP) (Chalfant et al 1999, Dobrowsky et al 1993, Law and Rossie 
1995, Wolff et al 1994) , protein kinase C (PKC) isoforms: (PKC)-alpha and –delta (Huwiler 
et al 1998), PKC-eta (Kashiwagi et al 2002b), PKC-zeta (Müller et al 1995) and cathepsin D 
(Heinrich et al 1999). An interaction of ceramide with its targets can be direct or indirect; 
however, the mechanisms underlying these interactions are not yet well known. Some of the 
direct interactions of ceramide to its targets have been clearly described: Ceramide for 
instance directly interacts with calcium-dependent phospholipase A2 (cPLA2) via the calcium-
dependent phospholipid binding (CaLB) domain resulting in a pro-inflammatory response 
(Huwiler et al 2001). On the other hand, involvement of ceramide by indirect interactions has 
also been reported, involvement of ceramide in regulating ion channels: n-K+ channel (Kv1.3) 
(Gulbins et al 1997, Szabó et al 1996) and calcium release-activated calcium channels 
(CRAC) (Lepple-Wienhues et al 1999). 
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1.3.3 ACID SPHINGOMYELINASE (ASM) 
Acid sphingomyelinase (human: ASM, murine: Asm) (ASM EC 3.1.4.12) is one of the 
enzymes categorized as sphingomyelinases (SMases) identified to catalyze the hydrolysis of 
sphingomyelin to ceramide and phosphorylcholine. Depending on the optimum pH, SMases 
are divided into acid SMases, neutral SMases and alkaline SMases (Cheng et al 2002, Duan et 
al 2003, Quintern et al 1987, Stoffel 1999, Tomiuk et al 2000, Yamanaka and Suzuki 1982, 
Zou et al 1989). There exists three forms of neutral SMases: neutral SMase 1 (Tomiuk et al 
2000), neutral SMase 2 (Kim et al 2010) and neutral SMase 3 (Krut et al 2006). It has been 
shown that neutral SMases depend on magnesium (Mg2+) for their activity, whereas acid 
SMases do not require Mg2+ for activation (Liu and Hannun 1997). Though the alkaline 
SMase depicts the least studied enzyme out of the three, but its role in generating ceramide 
with anti-proliferating and anti-inflammatory functions has also been recognized (Hertervig et 
al 2003, Wu et al 2005, Wu et al 2006).  
Among these SMases, ASM is the best characterized enzymes. This enzyme received a lot of 
attention when studies revealed its role in a genetically inherited disorder known as the 
Niemann-Pick disease (NPD) types A and B (Brady et al 1966, Horinouchi et al 1995, 
Schneider and Kennedy 1967). In both types, the sphingomyelin phosphodiesterase 1 
(SMPD1) gene encoding ASM is mutated. NPD A appears during infancy with a fast 
accelerating atrophy of the nervous system leading to early childhood death, whereas NPD B, 
known as non-neurological type, does not involve the nervous system but has rather 
aggressive impacts on various organs leading to retarded growth, lung infections, 
hepatosplenomegaly etc. (Schuchman and Miranda 1997). NPD A remains to be a fatal 
disorder with rapid neurodegenerative progress resulting in death by 2-3 years whereas NPD 
B, a benign form is seen to occur with later outbreak and prolong survival. Clinically, these 
two forms of NPD are differentiated by the amount of lysosomal ASM activity (Graber et al 
1994). 
Two types of ASM are characterized based on their localization: lysosomal sphingomyelinase 
(L-SMase) (Fowler 1969, Jenkins et al 2011) and secretory sphingomyelinase (S-SMase) 
(Schissel et al 1996). The name L-SMase hints at its being located in lysosomes, whereas the 
S-SMase is secreted into the serum (Schissel et al 1998). The two ASM forms differ in the 
trafficking process controlled by the same protein precursor. There exists distinct 
glycosylation pattern between L-SMase and S-SMase: S-SMase is transported to plasma 
membrane via Golgi secretory pathway in contrast to L-SMase which depends on lysosomal 
trafficking (Schissel et al 1998). L-SMase is known to be independent of Zinc (Zn2+) for its 
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activation in contrast to S-SMase (Schissel et al 1996, Schissel et al 1998). The role of L-
SMase in mediating apoptosis is also been reported. Its involvement in activating Bcl-2-
associated X protein (BAX) by stimulating apoptotic cascade signaling (Jin et al 2008a, 
Kashkar et al 2005), mitochondrial dysfunction (Zeidan et al 2008b), and activation of 
caspases with the involvement of cathepsin D (Heinrich et al 2004) has been well described. 
Compared to L-SMase, the role and function of S-SMase in stimulating ceramide production 
and inducing cells death is unclear to date, but an increase in the level and activity of S-
SMase in serum has been found in multiple diseases, for instance in chronic heart failure 
(Doehner et al 2007), hemophagocytic lymphohistiocytosis (Takahashi et al 2002), severe 
sepsis (Claus et al 2005), type 2 diabetes (Górska et al 2003) and in context to spatially 
fractionated radiation treatment (Sathishkumar et al 2005). 
 
1.3.4 ASM ENZYMOLOGY 
Identified as a lysosomal enzyme (Fowler 1969), ASM was first purified and characterized 
from human sources like placenta, brain, urine etc. (Lansmann et al 1996, Quintern et al 1987, 
Sakuragawa 1982, Yamanaka and Suzuki 1982). The gene encoding ASM, designated as 
SMPD1, was isolated and further cloned and characterized (Quintern et al 1989, Schuchman 
et al 1992). 
ASM protein possessing 629 amino acid exists in a monomeric form with a molecular weight 
of ~ 72 kDa, de-glycosylation reduces the protein to a molecular weight of ~ 60 kDa (Hurwitz 
et al 1994, Lansmann et al 1996). Further findings revealed that ASM complementary DNA 
(cDNA)-transfected COS-1 cells show the existence of two different forms: a 70 kDa ASM 
which is sited in lysosomal compartment, proteolytic cleavage results in the second ASM 
form with of 57 kDa, which is secreted. In contrast to the mature 70 kDa form, the latter 57 
kDa ASM does not possess an oligomannosyl-phosphate residue (Ferlinz et al 1994). Using 
site-directed mutagenesis, the N-glycosylation sites of ASM was identified, showing that five 
out of these six sites were occupied. Eviction of two C-terminal N-glycosylation sites resulted 
in disturbed enzyme formation and activity whereas no observational changes were seen when 
the remaining four N-terminal glycosylation sites were removed (Ferlinz et al 1997).  
ASM possesses 17 cysteine residues out of which only 16 cysteines are used for forming 8 
intramolecular disulfide bonds; the C-terminal cysteine (Cys629) remains free (Lansmann et 
al 2003) and is involved in activating ASM; modification and deletion of C-terminal cysteine 
(Cys629) resulted in an increase activity of ASM. Cys629 was reported to be involved in the 
activation mechanism of the ASM and dimerization of enzyme via an oxidation reaction (Qiu 
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et al 2003). Thus it might be taken into consideration that C-terminal cysteine (Cys629) is an 
important factor involved in the regulation and activation of ASM. 
 
Figure 1.3.4: ASM disulfide bond and domain structure arrangement. The disulfide bond 
pattern is shown as the activator domains containing three bonds (C120-131, C89-C165, C92-
C157) and the catalytic domain containing five bonds (C221-C226, C227-C250, C385-431, 
C584-C588, C594-C607) (Lansmann et al 2003). 
 
1.3.5 ASM/CERAMIDE AND CERAMIDE-ENRICHED MEMBRANE PLATFORMS 
Formation of ceramide and ceramide-enriched membrane platforms with the involvement of 
activated ASM has been shown to occur upon various stimuli including bacterial and viruses 
infection, death receptors, radiation, ultraviolet (UV)-light etc. (for complete details about 
stimuli and reference see Table 1). Activation of ASM is also known to be related to its 
translocation from lysosome to plasma membrane (Grassmé et al 2001a, Perrotta et al 2010). 
Hydrolysis of sphingomyelin in the presence of ASM or S-SMase results in the generation of 
ceramide (see section 1.3.3). These molecules have the tendency to rapidly fuse and form 
small ceramide-enriched membrane microdomains. The small microdomains again fuse 
resulting in the formation of ceramide-enriched membrane macrodomains (ceramide-enriched 
membrane platforms) (Grassmé et al 2001a, Grassmé et al 2001b, Megha and London 2004).  
In general ceramide-enriched membrane platforms can intrigue various receptor molecules 
such as cluster of differentiation (CD)95 (Grassmé et al 2001a, Grassmé et al 2001b), CD40 
(Grassmé et al 2002a) , FcγRII (Abdel Shakor et al 2004) and CD20 (Bezombes et al 2004) 
and thus results in clustering and re-organization of these molecules, creating a high receptor 
density in the surface of cells. Thus by possessing the ability to stabilize and organize 
receptors molecules, the ceramide-enriched membrane platforms play an important role in 
transmitting intracellular cell death signals. 
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Figure 1.3.5: Formation of ceramide-enriched membrane platforms. The activation of 
ASM enzymes results in lipid raft alteration from the formation of small ceramide-enriched 
microdomains to ceramide-enriched macrodomains, i.e. membrane platforms. Ceramide-
enriched membrane platforms are able to trap various receptors and hence transfer cell death 
signals inside the cells (Bollinger et al 2005). 
 
Accordingly, role of ASM/ceramide and ceramide-enriched membrane platforms in infectious 
biology has also been marked in several studies. Ceramide-enriched membrane platforms was 
shown to be a central requirement for bacteria to infect the host cells, as found for Neisseria 
gonorrhoeae (N. gonorrhoeae), and Pseudomonas aeruginosa (P. aeruginosa) (Grassmé et al 
1997, Grassmé et al 2003b) or Rhinovirus and the Sindbis virus (Grassmé et al 2005, Jan et al 
2000). In human epithelial cells, an infection with the bacterium N. gonorrhoeae resulted in 
activation of ASM, production of ceramide and the generation of ceramide-enriched 
membrane platforms. A genetical or pharmacological inhibition of ASM however interrupted 
this event preventing the N. gonorrhoeae infection in human epithelial cells (Grassmé et al 
1997). In human neutrophils it was shown that ceramide-enriched membrane platforms 
reorganize the Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 
receptors and the intracellular signaling molecules resulting in an internalization of Opa52 
protein of N. gonorrhoeae bacteria (Hauck et al 2000). Studies from Grassmé and 
coworkers demonstrated that CD95 receptors clustered in ceramide-enriched membrane 
platforms might be involved in the apoptosis induction by P. aeruginosa (Grassmé et al 
2000). An infection of human epithelial cells with Rhinoviruses induces an uptake of viruses 
with further activation of ASM and formation of ceramide-enriched membrane platforms 
(Grassmé et al 2005). The role of ceramide-enriched membrane platforms in inducing the 
apoptotic cascade with an entry of Sindbis virus in neuroblastoma cells was also reported (Jan 
et al 2000). Similarly it was shown that Plasmodium falciparum (P. falciparum) expresses its 
own sphingomyelinase for generation of ceramide which is essential for erythrocyte infection 
with P. falciparum (Hanada et al 2002). 
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Similarly role of ASM/ceramide and ceramide-enriched membrane platforms has also been 
shown in context to chemotherapeutic drugs, radiation, UV-light and other stresses like ROS 
resulting in induction of apoptosis (for complete reference see Table 1). Upon irradiation 
various cells are able to activate ASM with generation of ceramide leading to apoptosis 
(Garcia-Barros et al 2003, Lee et al 2011, Morita et al 2000, Paris et al 2001, Peña et al 2000, 
Santana et al 1996). Requirement of ASM to induce apoptosis upon irradiation has been 
confirmed in cells as well as in mice model whereas deficiency of this enzyme has shown 
hindrance to this event (Santana et al 1996). Endothelial cells are the best-described example 
for radiation-induced apoptosis with the involvement of ASM (Garcia-Barros et al 2003, Paris 
et al 2001, Peña et al 2000). Upon irradiation, dose-dependent apoptosis was observed in 
central nervous system (CNS) of C57Bl/6 or C3H/HN mice and 20 % apoptosis was observed 
in endothelial cells whilst Asm knockout mice showed resistant up to 40 Gy (Peña et al 2000). 
Further studies showed that whole body irradiation of C57Bl/6 mice resulted in death of mice 
within 10-13 days with gastrointestinal (GI) syndrome. At 4 h after irradiation, apoptosis in 
the crypt/villus of micro vessels was noticed, severe apoptosis of endothelial cells at a dose 
rate 15 Gy was seen which corresponded with GI syndrome. Basic fibroblast growth factor 
(BFGF) administered intravenously abolished endothelial apoptosis and radiation-induced 
damage of crypt or failure of organs and GI death. Furthermore upon 15 Gy, protection of 
endothelial apoptosis and GI death in Asm-deficient mice was observed (Paris et al 2001). 
Similarly, involvement of BFGF as a savior from radiation-induced cell death in endothelial 
cells has also been significant in both in vivo and in vitro studies (Fuks et al 1994, Fuks et al 
1995). Intravenous BFGF was able to protect radiation pneumonitis in C3H/HeJ mice with 
increment lethal dose (LD) 50/180 from 20.75 Gy to 23.0 Gy (Fuks et al 1995). 
Apart from endothelial cells, oocytes of fertile female mice responded to radiation-induced 
Asm- dependent cell death. Apoptosis in oocytes was observed in Asm positive mice while 
Asm deficient mice rescued this phenomenon. When treated with sphingosine 1-phosphate 
(antagonist of ceramide), oocytes were protected against radiation as well as doxorubicin 
induced apoptotic cell death (Morita et al 2000). Along with radiation, UV-light is also 
involved in mediating ASM induced cell death (Charruyer et al 2005, Kashkar et al 2005, 
Rotolo et al 2005, Zhang et al 2001). Apoptosis induction was confirmed in ASM wild type B 
lymphocytes with results in activation of ASM, generation of ceramide leading to activation 
of signaling cascade of JNK whereas no such JNK activation was observed in ASM deficient 
B lymphocytes cells upon UV-light (Zhang et al 2001).  
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PATHOGENS 
(BACTERIA AND 
VIRUSES) 
RECEPTORS  CHEMOTHERAPEUTIC 
DRUGS /RADIATION 
AND OTHER 
STRESSES 
OTHER 
FACTORS 
Listeria 
monocytogenes 
(Utermöhlen et al 2003) 
CD5 
(Simarro et al 1999)  
Cisplatin 
(Lacour et al 2004, Zeidan et al 
2008a)  
Platelet activating 
factor 
(Predescu et al 2013, 
Samapati et al 2012)  
Measles virus 
(Avota et al 2011, 
Gassert et al 2009)  
CD14 
(Pfeiffer et al 2001)  
Cu2+-treatment 
(Lang et al 2007)  
Tumor necrosis 
factor (TNF) 
(Garcia-Ruiz et al 
2003, Schütze et al 
1992, Schütze et al 
1994)  
Mycobacterium avium 
(Utermöhlen et al 2008)  
CD20 
(Bezombes et al 2004) 
Doxorubicin 
(Dumitru et al 2007)  
Visfatin 
(Boini et al 2010)  
Neisseria gonorrhoeae 
(Grassmé et al 1997, 
Hauck et al 2000)  
CD28 
(Boucher et al 1995)  
Heat damage 
(Chung et al 2003)  
 
Pseudomonas 
aeruginosa 
(Grassmé et al 2003b, 
Zhang et al 2008)  
CD32 (FCγRII) 
(Abdel Shakor et al 
2004, Korzeniowski et 
al 2007) 
Ischemia-reperfusion injury 
(Yu et al 2000)  
 
Rhinoviruses 
(Dreschers et al 2007, 
Grassmé et al 2005, 
Miller et al 2012)  
CD38 
(Jia et al 2008) 
Oxidative stress 
(Li et al 2012, Zhang et al 2007)  
 
Salmonella 
typhimurium 
(McCollister et al 2007)  
CD40 
(Grassmé et al 2002b)  
Oxygen radicals 
(Scheel-Toellner et al 2004)  
 
Sindbis virus 
(Jan et al 2000)  
CD95 
(Cifone et al 1994, 
Cremesti et al 2001, 
Grassmé et al 2001a, 
Grassmé et al 2001b, 
Gulbins et al 1995, 
Perrotta et al 2010)  
 
UV-light 
(Charruyer et al 2005, Kashkar et 
al 2005, Rotolo et al 2005, Zhang 
et al 2001)  
 
Staphylococcus aureus 
(Esen et al 2001)  
CD95- death-inducing 
signaling complex 
γ-irradiation 
(Lee et al 2011, Paris et al 2001, 
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Table 1: Overview of various factors stimulating activation/translocation of ASM and 
formation of ceramide and ceramide-enriched membrane platforms. 
 
1.4 RADIATION AND ASM/CERAMIDE-INDUCED CELL DEATH 
1.4.1 INVOLVEMENT OF ASM AND CERAMIDE IN IRRADIATION-INDUCED CELL 
DEATH 
In treating various cancers like intraorbital tumors (Hein et al 2005), nasopharyngeal cancer 
(Hunt et al 2001, Wolden et al 2001), non-small-cell lung cancer (Grills et al 2003), pediatric 
tumors (Lee et al 2005a) or prostate cancer (Zelefsky et al 2001) radiation plays an important 
role and remains to date an important therapeutic option. In radiation therapy, high energy 
radiation is used to kill cancer cells by activating various cell death pathways (Zelefsky et al 
2001).  
DNA is identified as the primary target for triggering radiation-induced cell death (Radford 
1986, Ward 1988). The lesions induce by IR results in formation of DNA single or double 
strand breaks. The damage in DNA is lethal and leads to activation of signal transduction 
pathways initiating various cellular responses one of which includes apoptosis (Crompton 
1998). An alternative to this model with the involvement to sphingomyelin pathway in 
mediating radiation-induced apoptosis was provided. It was demonstrated that in bovine aortic 
endothelial cells (BAECs) radiation targets cell membrane resulting in activation of 
sphingomyelinase leading to hydrolysis of sphingomyelin to produce ceramide. The ceramide 
thus produced can activate apoptotic pathways (Haimovitz-Friedman et al 1994). 
(DISC) 
(Grassmé et al 2003a) 
Santana et al 1996)  
 CD253  TNF-related 
apoptosis-inducing 
ligand (TRAIL) 
(Dumitru and Gulbins 
2006, Dumitru et al 
2007, Li et al 2013b)  
  
 interleukin (IL)-1 
receptor 
(Mathias et al 1993)  
  
 TNF-receptor 
(Ardestani et al 2013, 
Edelmann et al 2011)  
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Participation of ASM/ceramide in mediating radiation induced cell death process both in vivo 
and in vitro conditions has been remarked many times in studies (Garcia-Barros et al 2003, 
Lee et al 2011, Morita et al 2000, Paris et al 2001, Peña et al 2000, Santana et al 1996). The 
role of ASM/ceramide was elucidated in lymphoblasts lacking ASM which were found to be 
insensitive towards IR. When irradiated with 20 Gy, lymphoblasts from NPD did not respond 
to IR-induced apoptotic cell death compared to normal lymphoblasts. This observation was 
reversed when ASM-cDNA was transferred using retroviral plasmids, which resulted in an 
increase of the ASM activity level, ceramide production and finally in apoptotic cell death. In 
addition, mice irradiated at a dose of 10 Gy responded by a vast increase in ceramide 
generation leading to apoptosis in lung, thymus and spleen tissues (Santana et al 1996).  
Endothelial cells are the best studied targets upon irradiation in mediating apoptosis with the 
involvement of ASM (Garcia-Barros et al 2003, Paris et al 2001, Peña et al 2000). A dose 
dependent apoptosis was observed in CNS of C57Bl/6 or C3H/HN mice upon irradiation 
wherein 20 % apoptosis of endothelial cells were already noticed within 12 h. In contrary 
resistant up to 40 Gy upon irradiation of CNS as well as endothelial cells was observed in 
Asm knockout mice (Peña et al 2000). Similarly irradiating whole body of C57Bl/6 mice 
resulted in death of mice within 10-13 days with gastrointestinal (GI) syndrome. Apoptosis in 
the crypt/villus of micro vessels and severe apoptosis of endothelial cells upon 15 Gy after 4 h 
was noticed. Administration of BFGF intravenously abrogated endothelial apoptosis and 
radiation-induced damage of crypt or failure of organs and GI death. In addition, protection of 
endothelial apoptosis and GI death in Asm-deficient mice was detected upon 15 Gy (Paris et 
al 2001). Furthermore role of BFGF as a protector from radiation-induced endothelial cell 
death has been observed in both in vivo and in vitro studies (Fuks et al 1994, Fuks et al 1995). 
Further studies showed ASM mediated apoptosis upon irradiation in ovary of fertile female 
mice. During embryogenesis Asm−/− mice are defective in the normal apoptotic deletion of 
fetal oocytes resulting in neonatal ovarian hyperplasia. Ex vivo studies confirmed that oocytes 
from Asm−/− mice, or wild-type oocytes treated with S1P (ceramide metabolite) prevented 
daunorubicin-induced apoptosis. It has to be mentioned that during this pathway BAX 
function downstream of ceramide and a dose of 0.1 Gy resulted in 90 % loss of oocytes and 
infertility in wild-type female mice, however this phenomenon was abolished in vivo upon 
S1P administration (Morita et al 2000). 
IR-induced apoptosis by stimulating the sphingomyelin pathway had been identified much 
earlier (Haimovitz-Friedman et al 1994) than the involvement of de novo pathway. Transient 
ceramide produce within a few minutes after irradiation is known to be DNA–independent. 
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Whereas, ceramide generated several hours after irradiation depends on DNA regulating the 
Ataxia telangiectasia mutated (ATM) signaling pathway (Vit and Rosselli 2003). Similarly, 
involvement of the de novo pathway in generating ceramide leading to apoptotic cell death in 
prostate cancer cell line DU145 was also reported. DU145 cells are resistant to IR-induced 
cell death but these cells showed synergistically high levels of ceramide production ultimately 
leading to clonogenic cell death (Scarlatti et al 2007) when treated with IR in combination 
with resveratrol (3,5,4′-trans-trihydroxystilbene), one of the natural grapes products having 
chemotherapeutic characteristics (Gusman et al 2001, Jang et al 1997). The findings for IR-
induced apoptotic cell death through ceramide were not only limited to cell lines or mice but 
were also confirmed in the nematode Caenorhabditis elegans (C. elegans). It was shown that 
DNA damage induced by radiation activates C. elegans p53-like protein 1 (CEP-1) (the 
homologue of p53) which is required for increasing the expression of the Bcl-2 homology 
region 3 (BH3)-only proteins EGL-1 and CED-13. This in turn activated apoptotic signaling 
in mitochondria showing that ceramide and CEP-1 might function in parallel further 
increasing ceramide accumulation in mitochondria upon irradiation leading to induction of 
apoptosis in germ cells (Deng et al 2008). 
Ceramide inducing apoptotic cell death has been one of the most important areas of 
biological research, its role in inhibiting various cell survival pathways with the involvement 
of phosphatidylinositol 3-kinase (PI3K), Akt, and BAD by promoting apoptosis has also 
been reported (Zundel and Giaccia 1998). However the fact that ceramide once degraded by 
either of the enzymes ceramidase or glycosyltransferase/glucosylceramide synthase (GCS) 
leads to formation of sphingosine, S1P and glycosylceramide which promote cell survival 
pathways. Acid ceramidase (AC), an enzyme catalyzing the conversion of ceramide to 
sphingosine and fatty acid (Ferlinz et al 2001, Li et al 1998, Romiti et al 2000) is known to 
be a regulator of the de novo ceramide generation pathway. The role of AC-mediated 
ceramide consumption conferred resistant to radio-and chemotherapy in prostate cancer cells 
was shown upon various studies (Cheng et al 2013, Mahdy et al 2009, Saad et al 2007). In 
particular radiation resulted in an up-regulation of AC finally leading to resistance of prostate 
cancer cells; the addition of AC inhibitors reversed this condition, making the cells as well as 
xenograft model radiosensitive to IR (Cheng et al 2013, Mahdy et al 2009). Similarly, 
glioblastoma cells possess higher levels of ceramide glucosyltransferase/GCS, an enzyme 
responsible for the conversion of ceramide to glucosylceramide which protects the cells from 
undergoing programmed cell death (Dumitru et al 2009, Giussani et al 2012). As reported by 
Dumitru and coworkers upon gemcitabine treatment glioma cells were able to rapidly 
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consumed ceramide promoting cell survival however treatment of those cells with 
gemcitabine and GCS inhibitor DL-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-
propanol (PPMP) were able to restore the cellular ceramide level leading to cell death. It has 
to be noted that using AC inhibitor showed no effect on the colony forming ability of those 
cells upon gemcitabine treatment (Dumitru et al 2009). On the other hand using the GCS 
inhibitor PPMP alone reduced the clonogenic cell death in human glioma cell lines, but it did 
not show any synergistic effect in combination with IR (Gramatzki et al 2013). In Jurkat 
cells, the use of DL-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP), 
another inhibitor for GCS enzyme resulted in IR-induced apoptotic cell death (Rodriguez-
Lafrasse et al 2002).  
 
1.4.2 ROS PRODUCTION AND IONIZING RADIATION (IR) 
Various factors and/or stimuli like bacteria (Zhang et al 2008), chemotherapeutic drugs (Perez 
et al 2015), IR (Leach et al 2001), UV-light (Charruyer et al 2005) etc. are known to be 
involved in accelerating mitochondrial or NADPH oxidase (NOX) ROS production. IR 
targets both the mitochondrial (Leach et al 2001, Saenko Iu et al 2011, Yamamori et al 2012) 
and the NOX pathway (Collins-Underwood et al 2008, Liu et al 2008, Tateishi et al 2008) for 
generating ROS. To enlighten these interactions further, an involvement of mitochondrial 
ROS during IR-induced apoptosis has also been reported (Leach et al 2001). Similarly 
mitochondrial dependent apoptosis with production of massive ROS upon low dose of 
radiation has been shown in mouse testicular cells (Fang et al 2013). In various myeloma 
cells, two distinct level of ROS release were observed upon irradiation, differing in their 
temporal occurrence and being correlated with caspases activation and cytochrome c release 
finally leading to apoptosis (Chen et al 2003).  
In addition to mitochondria, NOX remains to be the main contributor for ROS production 
upon irradiation (Collins-Underwood et al 2008). Different NOX components have their own 
role as IR-induced ROS generators: NOX proteins are seemingly involved in ROS production 
leading to apoptosis induction, particularly NOX1 appears to be the inducer of ROS 
generation: its mRNA levels were found upregulated after 10 Gy of irradiation (Tateishi et al 
2008). In HeLa cells, NOX is one of the most important sources to contribute IR-induced 
ROS production finally leading to cell death. It was shown that upon IR, dose-dependent up-
regulation of the membrane subunit gp91phox takes place and translocation of the 
cytoplasmic subunit of NOX: p47phox and its association with the other membrane subunits 
p22phox and gp91phox was also observed (Liu et al 2008). Furthermore, in prostate cancer 
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cells, radiation in combination with parthenolide (PN, a sesquiterpene lactone) resulted in 
ROS generation via NOX activation with the effect of cells being radiosensitive (Sun et al 
2010). 
 
1.4.3 PLASMA MEMBRANE TARGETED UPON IRRADIATION 
Hydrolysis of the sphingolipid sphingomyelin (SM) catalyzed by ASM results in generation 
of ceramide at the outer layer of the plasma membrane. Various stress stimuli like bacterial 
infection (Grassmé et al 2003b, Zhang et al 2008), death receptors (Cifone et al 1994, 
Cremesti et al 2001, Perrotta et al 2010), oxidative stress (Li et al 2012, Zhang et al 2007), 
UV-light (Charruyer et al 2005, Kashkar et al 2005, Rotolo et al 2005, Zhang et al 2001) 
including irradiation (Paris et al 2001, Santana et al 1996, Sathishkumar et al 2005) are known 
to be involved in ASM activation resulting in the production of ceramide. Some studies have 
reported that translocation of ASM to the outer leaflet of the cell membrane is an initial step 
for activation of ASM (Grassmé et al 2001a, Perrotta et al 2010). Grassmé and coworkers first 
demonstrated that stimulation of CD95 resulted in translocation of ASM to outer surface of 
the plasma membrane resulting in clustering of CD95 in sphingolipid-rich membrane rafts 
finally resulting in apoptosis in lymphocytes whereas ASM-deficient lymphocytes rescued 
these events preventing apoptosis (Grassmé et al 2001a). Similar study was carried out using 
human glioma cells U373 where CD95 stimulation resulted in ASM activation through its 
translocation from intracellular compartments to the plasma membrane with the involvement 
of target- (soluble N-ethylmaleimide-sensitive-factor activating protein receptor) (t-SNARE) 
protein syntaxin 4. Down regulation of syntaxin 4 resulted in prevention of ASM 
translocation and its activation when stimulated with CD95 resulting in inhibition of caspase 3 
and 9 activation finally rescuing apoptosis. These events leaded to activation of survival 
pathway (Perrotta et al 2010). In accordance, UV-light induced activation and translocation of 
ASM (Zn2+-independent) to the plasma membrane in the human myeloblastic cell line U937 
was also observed, the process was found to be ROS-dependent (Charruyer et al 2005). The 
role of ROS in monitoring UV-light-signaling had also been known before (Xing et al 2008). 
This phenomenon was validated using scavengers of ROS which overcome both ASM 
activation and its translocation to plasma membrane. ASM activation and translocation to 
plasma membrane resulted in ceramide generation which leaded to activation of the JNK 
pathway in human myeloblastic U937 cells (Charruyer et al 2005). Once ASM translocation 
and activation leads to formation of ceramide and ceramide-enriched platforms on plasma 
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membrane, the latter are able to cluster death receptors resulting in the induction of cell death 
(for details see section 1.3.5).  
When it comes to radiation, ROS are the main important factors in mediating IR-induced cell 
death by participating in the signaling cascade (Mikkelsen and Wardman 2003). One of the 
first event that takes place when cells are exposed to IR is the generation of ROS (see section 
1.1.1), and various enzymes are involved in IR-induced ROS generation, one of which is the 
NOX family (Collins-Underwood et al 2008, Liu et al 2008, Tateishi et al 2008). The 
ASM/ceramide pathway is known to be involved in IR-induced activation of NOX through 
formation of redox lipid rafts. The role of lipid rafts in redox signaling has been highlighted 
much in recent years. In coronary endothelial cells, upon Fas ligand (FasL) stimulation one of 
the NADPH oxidase (NOX) subunits, gp91phox, clustered in lipid rafts which further resulted 
in the translocation of other cytosolic subunits of NOX: p47 phox and Rac proteins to lipid 
rafts with an increase in full activity of NOX enzymes (Zhang et al 2006). Further studies 
showed involvement of both Asm and ceramide in lipid raft redox signaling. FasL stimulation 
resulted in increased ASM activity, production of ceramide, and LR clustering in coronary 
arterial endothelial cells (CAECs) however silencing Asm reversed this process. Silencing 
ASM using SiRNA resulted in inhibition of ceramide production and lipid raft clustering, 
finally leading to an inhibition of the NOX enzyme by blocking gp91phox aggregation and 
translocation of p47phox to the LR clusters (Zhang et al 2007). Though the complete 
mechanism of how ROS are mediating ASM activation has still not been elucidated, its 
particular role in activating ASM in airway epithelial cells has been cleared (Castillo et al 
2007).  
In addition IR is reported to change the organization of cytoskeleton (Friedman et al 1986, 
Gabrys et al 2007, Rousseau et al 2011). In shaping the cell structure, the cytoskeleton plays 
an important role. A linkage between both cell plasma membrane and actin cytoskeleton is 
formed by the interaction of lipid and protein molecules. Various proteins like glycophorin-
protein 4.1, profilin are involved in transmitting the signal from the cell plasma membrane to 
the actin cytoskeleton (Anderson and Marchesi 1985, Lassing and Lindberg 1985). One of the 
best-studied proteins in maintaining the actin cytoskeleton structure is the Rho family (Rho, 
Rac and Cdc42) (Bishop and Hall 2000, Hall 1998, Helliwell et al 1998). Though the 
activation of these Rho proteins upon various factors one of which is IR has been repeatedly 
reported (Gabrys et al 2007, Zhai et al 2006), the accurate mechanism of IR activating Rho 
proteins is still unrevealed. However, as ceramide is known to activate Rho A (Gupta et al 
2001) and Rac-1 (Brenner et al 1997), it can be assumed that IR indirectly stimulates the 
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activation of these Rho proteins with the involvement of ceramide formation after irradiation. 
Activated GTPase, Rac-1, is further known to interact with the lipid rafts membrane domain 
(del Pozo et al 2004).  
 
 
Figure 1.4: Model showing how IR targets the plasma membrane and results in ASM 
activation and its translocation. IR-induced ROS production might be a regulator of ASM 
translocation from the lysosome to the plasma membrane. Once activated ASM leads to the 
formation of ceramide and ceramide-enriched membrane platforms which further mediate 
signal transduction inside the cells. Ceramide formed within the plasma membrane might 
regulate various other signaling molecules. 
 
1.5 AIMS OF THE STUDY 
Several studies has shown that tumor cells have the ability to prevent the accumulation of 
ceramide by decreasing the total cellular concentration of ceramide and escape from cell death 
process (Cheng et al 2013, Dumitru et al 2009, Giussani et al 2012, Mahdy et al 2009, Saad et 
al 2007). In particular, ceramide glycosyltransferase/glycosylceramide synthase (GCS) 
mediated ceramide consumption is one of the drawbacks for treating glioblastoma in response 
to chemotherapy and radiation. The inhibition of GCS sensitizes the glioblastoma cells upon 
different chemotherapeutic drugs like gemcitabine (Dumitru et al 2009), temozolomide and 
Paclitaxel (Giussani et al 2012). 
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The present study will investigate whether irradiation of human glioblastoma cells results in 
the activation of ASM, formation of ceramide-enriched membrane platforms and clustering of 
NADPH oxidase in the plasma membrane.  
 
Furthermore we will address the mechanism of ASM activation by testing if irradiating the 
cells induces free radical oxygen production which might mediate activation of the ASM. 
 
The last part of the study will focus on identification of the interacting partners for ASM, 
ceramide and lipid rafts which might suggest if some the identified proteins are involved in 
conferring radioresistance in glioblastoma cells upon irradiation. 
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2 MATERIALS 
2.1 LIST OF CHEMICALS 
Acetic acid (CH3COOH) 
 
Merck KGaA, Darmstadt, Germany 
Acetone (C3H6O) 
 
Merck KGaA, Darmstadt, Germany 
Acrylamide (C3H5NO) Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Adenosine Tri-Phosphate (ATP) Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Agarose 
 
Gibco, Invitrogen,Karlsruhe, Germany 
Ammonium persulfate (APS) 
 
Carl-Roth GmbH & Co, Karlsruhe, Germany 
Apocynin 
 
Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Bovine serum albumin (BSA) Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Bradford reagent  
 
Bio-Rad, USA 
Bromophenol blue Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Cardiolipin Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Chloroform (CHCl3) 
 
Applichem GmbH, Darmstadt, Germany  
Crystal violet (C25H30ClN3) 
 
 
Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
1,4-diazabicyclo[2.2.2]octane (C6H12N2) 
(DABCO) 
 
Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Deoxycholic acid (C24H40O4) 
 
Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Deoxyribonucleotides (dNTP´s) 
 
Bio-Budget Technologies GmbH, Krefeld, 
Germany and PEQLAB Biotechnology 
GmbH, Erlangen, Germany 
Diethylenetriaminepentaacetic acid 
(DETAPAC) 
Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Dithiothreitol (DTT) Carl-Roth GmbH & Co, Karlsruhe, Germany 
 
Dulbecco's modified eagle's 
medium (DMEM) 
 
Gibco Life Technologies,USA 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich Chemie GmbH, 
  
41 MATERIALS 
Steinheim, Germany 
2',7' – dichlorodihydrofluorescein diacetate 
(H2DCFDA) 
 
Life Technologies, USA 
Enhanced chemiluminescence (ECL) 
 
Thermo Scientific, USA 
Ethanol (CH3CH2OH) 
 
Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Ethidium bromide Serva Electrophoresis GmbH, Heidelberg, 
Germany 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Fetal calf serum (FCS) 
 
Gibco, Invitrogen, Karlsruhe, Germany 
Glucose (C6H12O6) 
 
Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Glycerol (C3H8O3) 
 
Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Glycine (C2H5NO2) 
 
Applichem, GmbH, Darmstadt, Germany 
HEPES Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Hydrochloric acid (HCl) 
 
J.T. Baker, USA 
Imidazole (C₃H4N2) Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Magnesium sulphate (MgSO4) Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
2-(N-morpholino) ethanesulfonic acid 
(MES) 
Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
2-Mercaptoethanol Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Methanol (CH₃OH) 
 
J.T. Baker, USA 
Monopotassium phosphate (KH2PO4) 
 
Merck KGaA, Darmstadt, Germany 
Mowiol Kuraray Specialities Europe GmbH, 
Frankfurt, Germany 
N-octylglucopyranoside Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Nonfat dry milk powder 
 
Applichem, GmbH, Darmstadt, Germany 
Nonidet P-40 (NP-40) Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Paraformaldehyde (PFA) Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Penicillin/Streptomycin 
 
Gibco, Invitrogen,Karlsruhe, Germany 
Poly-L-lysine ((C6H12N2O)n) Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
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Potassium chloride (KCl) 
 
Carl-Roth GmbH & Co, Karlsruhe, Germany 
Protease inhibitor Carl-Roth GmbH & Co, Karlsruhe, Germany 
 
Scintillation cocktail 
 
Beckman Coulter, Fullerton, CA, USA 
Sodium acetate (CH3COONa) 
 
Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Sodium chloride (NaCl) Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Sodium deoxycholate (C24H39NaO4) 
 
Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Sodium dodecyl sulphate 
(CH3(CH2)11OSO3Na) (SDS) 
 
Carl-Roth GmbH & Co, Karlsruhe, Germany 
Sodium hydroxide (NaOH) Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Sodium phosphate (Na3PO4) 
 
Merck, Darmstadt, Germany 
Sucrose (C12H22O11) 
 
Carl-Roth GmbH & Co, Karlsruhe, Germany 
Sodium carbonate (Na2CO3) Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Taq Polymerase Invitrogen, Karlsruhe, Germany 
 
Tetramethylethylendiamine (C6H16N2) 
(TEMED) 
Applichem, GmbH, Darmstadt, Germany 
Tiron (C6H4Na2O8S2) Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Tricine (C6H13NO5) Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
Tris(hydroxymethyl)aminomethane 
(NH2C(CH2OH)3) (Tris) 
Carl-Roth GmbH & Co, Karlsruhe, Germany 
Triton X-100  Sigma-Aldrich Chemie GmbH, steinheim, 
Germany 
Trypsin 
 
Biochrom Berlin, Germany 
Tween-20 (C58H114O26) Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany 
 
2.2 LIST OF ANTIBODIES, TRANSFECTION REAGENTS, PROTEIN BEADS AND 
LIPID BEADS  
2.2.1 PRIMARY ANTIBODIES 
Antigen Host Dilution Supplier 
Acid 
sphingomyelinase, 
Rabbit 1:50 Areta International 
s.r.l. Gerenzano, Italy 
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ASM (for microscopic 
staining) 
Acid 
sphingomyelinase, 
ASM (for 
immunoprecipitation 
and western blotting) 
Mouse 1:1000 Abcam, Cambridge, 
UK 
Calnexin 
 
Mouse 1:1000 BD Biosciences, 
USA 
Ceramide Mouse 1:50 Enzo life sciences, 
Germany 
COX-IV Goat 1:1000 Santa Cruz 
Biotechnology, USA 
Flotillin-1 Rabbit 1:1000 Santa Cruz 
Biotechnology, USA 
gp91phox (for 
microscopic staining) 
Rabbit 1:50 Abcam, Cambridge, 
UK 
gp91phox (for 
western blotting) 
Rabbit 1:1000 Proteintech, Chicago, 
USA 
LAMP-1 Rabbit 1:1000 Santa Cruz 
Biotechnology, USA 
TIMM23 (for 
microscopic staining) 
Rabbit 1:50 Proteintech, Chicago, 
USA 
TIMM23 (for western 
blotting) 
Rabbit 1:1000 Proteintech, Chicago, 
USA 
 
2.2.2 SECONDARY ANTIBODIES 
Antigen Host Conjugation Dilution Supplier 
Beta-actin Mouse HRP 1:2000 Cell signaling, 
USA 
Mouse IgM Donkey Cy3 1:250 Jackson 
ImmunoResearch  
Laboratories, 
USA 
Rabbit IgG Donkey Cy5 1:250 Jackson 
ImmunoResearch  
Laboratories, 
USA 
Rabbit IgG Donkey FITC 1:250 Jackson 
ImmunoResearch  
Laboratories, 
USA 
Rabbit IgG Rabbit HRP 1:2000 Cell signaling, 
USA 
Mouse IgM Mouse HRP 1:2000 Cell signaling, 
USA 
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2.2.3 TRANSFECTION REAGENTS 
Transfection materials Supplier 
gp91phox/cytochrome b beta (CYBB) siRNA 
(ID 3915) (AM16708) 
 
Ambion, Inc., Austin, TX, USA 
Negative control siRNA (AM 4611)  
 
Ambion, Inc., Austin, TX, USA 
Ribonuclease (RNAse) free H2O 
 
Ambion, Inc., Austin, TX, USA 
Transfection kit (containing EC buffer + 
enhancer + effectene transfection reagent) 
(Cat.no. 301425) 
 
Qiagen, GmbH, Hilden, Germany 
 
2.2.4 PROTEIN BEADS AND LIPID BEADS  
Beads Supplier 
Ceramide beads (P-BCer) Echelon Biosciences, USA 
 
Control beads (P-B000) Echelon Biosciences, USA 
 
Protein A/G PLUS-Agarose 
beads  sc-2003 
Santa Cruz Biotechnology, 
USA 
 
2.3 LIST OF CELL CULTURE MATERIALS 
2.3.1 OVERVIEW OF CELL CULTURE MATERIALS 
Round bottom petri dishes 35 mm BD Falcon, USA 
Tissue culture flasks 25cm² TPP, Trasadingen, Switzerland 
Tissue culture flasks 75cm² TPP, Trasadingen, Switzerland 
Tissue culture petri dishes (100, 60, 30 mm) TPP, Trasadingen, Switzerland 
Tissue culture 6 well plates TPP, Trasadingen, Switzerland 
 
2.3.2 PREPARATION OF CELL CULTURE MEDIA AND BUFFERS 
Culture medium for A172 and LN308  
 
500 ml DMEM  
10 % FCS 
1 % Antibiotics (10,000 units of penicillin 
and 10,000 µg of streptomycin) 
Freezing medium 95 ml DMEM 
5 ml FCS 
5 ml DMSO 
Trypsin 0.25 % Trypsin 
5 mM Glucose 
1.3 mM EDTA in PBS 
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2.4 CELL LINES 
A172 Established human glioblastoma cell line 
(Prof. Michael Weller, Department of 
Neurology, University Hospital Zurich, 
Switzerland) 
LN308 Established human glioblastoma cell line 
(Prof. Michael Weller, Department of 
Neurology, University Hospital Zurich, 
Switzerland) 
 
Mycoplasma contamination was monthly tested in all cell lines by PCR. 
 
2.5 PCR PRIMERS 
Myco P1  
5' –GTG CCA GCA GCC GCG GTA ATA 
C- 3' 
Hölle & Hüttner AG, Germany 
Myco P4  
5' –TAC CTT GTT ACG ACT TCA CCC 
CA- 3' 
Hölle & Hüttner AG, Germany 
 
2.6 RADIOACTIVE SUBSTRATES 
[32P]γ-ATP Hartmann Analytic, Braunschweig, Germany 
[14C]sphingomyelin PerkinElmer, Boston, MA, USA 
 
2.7 OTHER MATERIALS 
Cell culture:  
Conical centrifuge tubes (15 and 50 ml) 
 
BD Falcon, USA 
Cryo 1C Freezing container 
 
Nalgene, USA 
FACS polystyrene round-bottom tubes Becton, Dickinson and Company, Le Point 
de Claix, France 
Neubauer chamber 0.1 mm 
 
Marienfeld, Germany 
Immunoblotting  
Cell scraper TPP, Trasadingen, Switzerland 
Cuvettes 10 x 4 x 45 mm 
 
Sarstedt, Nümbrecht, Germany 
Hybond blotting membranes 
 
Amersham Biosciences, Buckinghamshire, 
UK 
Whatman filter paper 
 
Whatman, Maidstone, UK 
X-Ray films FUJIFILM Medical Systems, Stamford, USA 
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Immunostaining:  
Cover slips 12 mm diameter 
 
Carl-Roth GmbH & Co, Karlsruhe, Germany 
Microscopic slides Engelbrecht Medizin und labortechnik 
GmbH, Germany 
Parafilm 
 
Peckiney, Chicago, IL, USA 
Mass spectrometry:  
Dounce (glass-glass) homogenizer 
 
Wheaton Science Products, Millville, USA 
Ultracentrifuge tubes 
 
Beckman Coulter, Germany 
Others:  
Dihydroethidium (DHE) 
 
Life Technologies, USA 
H2DCFDA 
 
Life Technologies, USA 
Hoechst 33342 
 
Life Technologies, USA 
MitoSOX red 
 
Life Technologies, USA 
Mitochondria isolation kit for cultured cells 
(89874) 
Thermo Scientific, Life Technologies GmbH, 
Germany 
NADPH assay kit (Cat.no. CY0100) Sigma-Aldrich, Germany 
Propidium iodide (PI) Sigma-Aldrich, Germany 
Silica G60 TLC plates Merck, Darmstadt, Germany 
 
2.8 LABORATORY EQUIPMENT  
BD FACSCalibur flow cytometer 
 
BD Biosciences, San Jose, CA, USA 
Cell culture incubator 
 
ThermoFisher Scientific,Waltham, MA, USA 
Fluorescence microplate reader 
 
BMG Labtech, Offenburg, Germany 
Leica TCS SP5 laser scanning confocal 
microscope 
Leica Microsystems GmbH, Mannheim, 
Germany 
Portable datalogging spectrophotometer 
 
Bachofer, Reutlingen, Germany 
Phosphorimager 
 
FUJIFILM Medical Systems, Stamford, USA 
Real-Time PCR system ABI PRISM® 7300 Real-Time PCR System, 
Applied Biosystems, Foster City, CA, USA 
SpeedVac (Vacuum Concentrator) 
 
Bachofer, Reutlingen, Germany 
Sonorex bath sonicator 
 
Bandelin electronic, Berlin, Germany 
TriCarb liquid scintillation analyzer Perkin Elmer, USA 
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Thermomixer 
 
Eppendorf, Germany 
TLA-55 rotor 
 
Beckman Coulter, Germany 
Rotary agitator Neolab Migge Laborbedarf-Vertriebs GmbH, 
Germany 
Ultracentrifuge 
 
Beckman Coulter, Germany 
 
2.9 LISTS OF COMPLETE GELS, BUFFERS AND SOLUTIONS 
2.9.1 BUFFERS AND SOLUTIONS FOR WESTERN BLOTTING 
APS 10 % APS 
In ddH2O 
Blocking buffer 5 % of non-fat dry milk powder in TBST (see 
below) 
Primary antibodies dilution buffer 5 % of BSA in TBST (see below) 
Running gel (10%) 3.75 ml Solution A (see below) 
5.0 ml Solution B (see below) 
6.11 ml H2O 
75 µl 20 % SDS 
30 µl TEMED 
30 µl 10 % APS in H2O 
SDS lysis buffer 25 mM HEPES pH 7.4 
0.1 % SDS 
0.5 % Deoxycholic acid 
1 % Triton X-100 
10 mM EDTA 
10 mM Sodium pyrophosphate 
10 mM Sodium fluoride 
125 mM NaCl 
SDS sample buffer (5x) 62.5 mM Tris pH 6.8 
10 % Glycerol 
2 % SDS 
0.04 % Bromphenol blue 
5 % 2-Mercaptoethanol 
Solution A 40 % Acrylamide 
(39.2 g Acrylamide /100 ml; 
0.8 g Bis-Acrylamide /100 ml) 
Solution B 3M Tris pH 8.8 
Solution C 3M Tris pH 6.8 
Stacking gel 0.63 ml Solution A 
0.21 ml Solution C 
4.1 ml H2O 
0.025 ml 20 % SDS 
0.02 ml TEMED 
0.02 ml 10 % APS in H2O 
Transfer buffer 25 mM Tris 
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192 mM Glycine 
20 % Methanol 
10 x Tris-buffered saline and 0.1% Tween-20 
(TBST) (washing buffer) 
200 mM Tris pH 7.4 
1500 mM NaCl 
1 % Tween-20 
Secondary antibodies dilution buffer 5 % of non-fat dry milk powder in TBST  
 
2.9.2 BUFFERS AND SOLUTIONS FOR VARIOUS EXPERIMENTS 
ASM lysis buffer 250 mM Sodium acetate pH 5.0  
1.3 mM EDTA 
0.1 % NP-40 
DAG-assay buffered saline solution 135 mM NaCl 
1.5 mM CaCl2 
0.5 mM MgCl2 
5.6 mM Glucose 
10 mM HEPES pH 7.2 
DAG-assay detergent solution 7.5% N-octylglucopyranoside 
5 mM Cardiolipin 
1mM DETAPAC 
DAG-kinase diluents 1 mM DETAPAC pH 6.6 
0.01 M imidazole/HCl  
DAG-kinase reaction buffer 100 mM imidazole/HCl pH 6.6 
100 mM NaCl 
25 mM MgCl2 
2 mM EDTA 
2.8 mM DTT 
5 μM ATP 
10 μCi [32P]-γ ATP 
10x HEPES-saline 200 mM HEPES 
1.32 M NaCl 
10 mM CaCl2 
7 mM MgCl2 
8 mM MgSO4 
54 mM KCl 
(NADPH activity assay) Enzyme dilution 
buffer 
300 mM Potassium phosphate buffer, pH 7.8, 
containing 0.1 mM EDTA and 0.5 mg/ml 
bovine serum albumin 
(NADPH activity assay) Working solution 9 mg Cytochrome c  
20 ml Assay buffer (300 mM potassium 
phosphate buffer, pH 7.8, containing 0.1 mM 
EDTA) 
NADPH stock solution 
(40 mg/ml)  
25 mg NADPH   
0.625 ml of H2O 
PBS 137 mM NaCl  
2.7 mM KCl 
7 mM CaCl2 
0.8 mM MgSO4 
1.4 mM KH2PO4 
6.5 mM Na2HPO4 
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Adjust pH to 7.6 
PCR buffer (10x) 200 mM Tris-HCl pH 8.3 
500 mM KCl 
14 mM MgCl2 
0.1% Gelatin 
10 x Tris/Borate/EDTA (TBE) buffer 890 mM Tris Base  
890 mM Boric Acid  
20 mM EDTA 
Tissue Lysis Buffer (TLB) 10 % 10 x PCR buffer  
0.5 mM MgCl2 
0.045 % Tween-20  
0.045 % NP-40  
300 µg/ml Proteinase K 
 
2.9.3 BUFFERS AND SOLUTIONS FOR IMMUNOSTAINING (FLUORESCENCE 
MICROSCOPY) 
Antibodies dilution buffer 1 % BSA 
in PBS 
Mowiol 6 g Glycerol 
2.4 g Mowiol 
6 ml H2O 
12 ml 0.2 M Tris pH 8.5 
0.1 % DABCO 
PBS + 1 % BSA (blocking buffer) 1 % BSA 
in PBS 
PBS + 0.2 % BSA (washing buffer) 0.2 % BSA 
in PBS 
1 % PFA (fixing solution) 1 % PFA 
in PBS 
 
2.9.4 BUFFERS AND SOLUTIONS FOR MASS SPECTROMETRY 
(ceramide pull-down assay) Wash/binding 
buffer 
10 mM HEPES, pH 7.4 
150 mM NaCl 
0.25 % NP-40 
90 % sucrose  
 
45 g Sucrose 
MBS until volume equals 50 ml 
Heat in a microwave oven (in 10-s intervals) 
to dissolve/melt 
35 % sucrose 
 
5.83 ml 90 % Sucrose  
9.17 ml MBS/Na2CO3 (see below) 
5 % sucrose 0.83 ml 90 % Sucrose  
14.17 ml MBS/Na2CO3 (see below) 
MBS/Na2CO3 
 
250 mM Na2CO3 in MBS (see below) 
Membrane lysis buffer 
 
0.25 M Sucrose 
1 mM EDTA 
20 mM Tricine, pH 7.8 
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2-(N-morpholino)ethanesulfonic acid (MES)-
buffered saline (MBS) 
 
25 mM MES 
150 mM NaCl, pH 6.0 
RIPA buffer 10x 1 % NP40 
0.1% SDS 
50 mM Tris-HCl pH 7.4 
150 mM NaCl 
0.5 % C24H39NaO4 
1 mM EDTA 
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3 METHODS 
3.1 CELL CULTURE TECHNIQUES 
3.1.1 CULTURE OF ESTABLISHED CELL LINES 
3.1.1.1 Cell line and Culture conditions 
Adherent human glioblastoma cell lines A172 and LN308 were cultured in T75 cm² flasks. 
Cells were maintained in a complete culture medium containing DMEM, supplemented with 
10 % FCS, 10000 units of penicillin and 10000 µg of streptomycin per ml at 37°C in an 
incubator with 5 % CO2. Before passaging the cells, the medium, PBS and trypsin were pre-
warmed at 37°C. Cells were washed with PBS, followed by detaching the latter using trypsin. 
Fresh medium was added, and cells were collected and transferred to new flasks followed by 
incubation at 37°C until use. 
 
3.1.1.2 Freezing of cells 
Cells were frozen by using a cryo-preserving method. Cells from T75 cm² or T25 cm² flasks 
were trypsinized and collected by centrifugation. Pellets were re-suspended in freezing 
medium (see section 2.3.2). DMSO was added to the freezing medium to avoid ice crystals 
formations within the cells during the freezing procedure. 1 ml of the re-suspended solution 
was added to cryogenic vials with proper labeling and stored at -80°C for short-term use. For 
long-term storage, cryogenic vials were kept in a liquid nitrogen container. 
 
3.2 DNA TECHNIQUES 
3.2.1 POLYMERASE CHAIN REACTION (PCR) 
3.2.1.1 DNA isolation from cell line 
To test the mycoplasma contamination within the used cell lines, DNA was isolated from the 
cells in the following way: 10 x 105 cells / sample were collected by centrifugation for 5 min 
at 100 x g and 4°C. Supernatant was discarded, and the pellets were suspended in 50 µl TLB 
(see section 2.9.2) followed by incubation for 3 h at 56°C with smooth shaking. Afterwards, 
the samples were boiled for 10 min at 95°C and 100 µl of autoclaved ddH2O was added to the 
boiled samples. 
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3.2.1.2 Mycoplasma PCR 
For analyzing the mycoplasma detection by PCR, following mixture was prepared: 
 
Table for reagent added: 
Reaction component Amount 
H2O 18.75 µl 
10X PCR-Buffer B 2.5 µl 
25 mM MgCl2 1.5 µl 
10 mM deoxynucleotide triphosphates 
(dNTP`s) 
0.5 µl 
Primer P1 0.25 µl 
Primer P4 0.25 µl 
Taq Polymerase  0.25 µl 
DNA (see section 3.2.1) 1 µl 
                                                                              Total Volume = 25 µl 
Samples were then kept in a thermo-cycler; PCR temperature was increased to 104°C, and the 
temperature of the PCR block was raised to 96°C for 17 min, followed by this (below) cycle 
which was carried out 25 times: 
 Denaturation: 95°C for 1 min 
 Annealing: 60°C for 1 min 
 Elongation: 72°C for 1 min 30 sec 
After the last cycle, the PCR block was remained at 72°C for 7 min, after which the samples 
were placed at 4°C. 
 
3.2.2 AGAROSE GEL ELECTROPHORESIS 
To analyze the sample after the PCR, 0.8 % agarose gel was prepared and poured in TBE 
buffer (see section 2.9.2) containing 0.01 μg/ml ethidium bromide. The Samples (15μl) along 
with 0.1 μg/μl of a 100-bp-standard were loaded on the gel. 5 V /cm current were then used to 
run the gel, and DNA fragments were visualized under UV-light. 
 
3.3 IONIZING RADIATION (IR) TREATMENT 
Irradiation of cells was carried out at room temperature (RT) using an X-ray machine, 
operated at a maximum energy of 320 kilovolt (kV) with a 1.65-mm aluminum filter 
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(effective photon energy approximately 90 kV), at a distance of 50 cm for 35 mm and 60 mm 
petri dishes whereas while using 100 mm petri dishes the distance was maintained at 75 cm. 
The irradiation table was kept on rotating position during exposure of radiation to ensure 
consistent irradiation. The dose rate of 4 Gray (Gy) was used in all experiments, except for 
the dose-and time-dependent cell death assay (section 3.4) where different doses starting from 
2 Gy till 8 Gy were used.  
 
3.4 PROPIDIUM IODIDE (PI) STAINING FOR CELL DEATH QUANTIFICATION 
To determine the dose-dependent cell death, 1.0 x 105 cells were plated per 60 mm petri dish 
24 h prior to irradiation. The next day, cells were treated with different doses of IR as 
indicated (0, 2, 4, 6 and 8 Gy) and remained in the incubator for 96 h. After 96 h medium was 
removed and added in a 15 ml falcon tube, cells were washed once with PBS followed by 
addition of trypsin to detach the cells. Cells were collected and added to the same falcon tube 
containing medium and centrifuged at 4°C, 500 x g for 5 min. Supernatant was discarded and 
the pellets were washed once with PBS followed by the centrifugation. Finally pellets were 
re-suspended in PBS and 0.1 μl/mg of PI was added to each sample and incubated for 10 min 
at RT. Samples were measured in FL-2 channel. For time-dependent cell death quantification 
all the procedure was performed in the same way except that the cells were plated for three 
different time points i.e. 76 h, 96 h and 120 h and were irradiated with 4 Gy. At each time 
point, staining the cells with PI was carried out. 
 
3.5 ACID SPHINGOMYELINASE (ASM) ACTIVITY ASSAY 
To determine the activity of ASM, 2.0 x 106 cells / plate were seeded in a 35 mm petri dish 24 
h prior to irradiation. The next day, cells were treated with a 4 Gy; control cells remained non-
irradiated. At indicated time point, i.e. 10 and 15 min after IR, cells were washed with PBS 
and lysed in 400 µl of ice-cold ASM lysis buffer (see section 2.9.2). Non-irradiated samples 
were treated similarly. Lysates were collected with a cell scraper and transferred into a 
microcentrifuge tubes followed by three sonication cycles (3 x 10 s) using a tip sonicator. 
[14C]-labeled sphingomyelin was dried by SpeedVac centrifugation before adding to the 
lysates; since [14C]sphingomyelin is insoluble in water, it was suspended in ASM lysis buffer, 
followed by a 10 min sonification for the formation of micelles. Lysates were incubated with 
0.02 μCi of [14C]sphingomyelin for 30 min at 37°C in a thermomixer. The reaction was 
stopped by the addition of 0.8 ml of CHCl3:CH3OH (2:1,v/v), followed by vigorous vortexing 
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and centrifugation at 800 x g for 5 min. Phases were then separated by centrifugation at 
maximum speed as phosphorylcholine in the upper (aqueous) phase and ceramide in the lower 
(organic) phase. Carefully, 250 µl aliquot from the aqueous phase were collected and added to 
polyethylene vials containing 4 ml of scintillation cocktail for liquid scintillation counting. 
For measuring the ASM activity in presence of ROS inhibitors (apocynin and tiron), the 
experiment was carried out following the procedure mentioned above with slight changes. 
Prior to irradiation, the cells were incubated with 100 µM of respective ROS inhibitors for 30 
min at 37°C. After 30 min of incubation, cells were washed once with PBS and maintained 
with culture medium. 
ASM activity in control and gp91phox siRNA transfected cells were measured as described 
above. Cells were transfected with control and gp91phox siRNA as mentioned in section 3.11. 
 
3.6 FLUORESCENCE MICROSCOPY FOR CELL SURFACE MOLECULES AND 
COLOCALIZATION STAINING 
To determine the translocation of ASM and the clustering of ceramide on the plasma 
membrane, 2.0 x106 cells were plated per 35 mm petri dish with a round coverslip in it. 
Before using, 500 µl of poly-L-lysine solution were added to the coverslip and incubated for 
10 min under a sterile hood, followed by washing once with PBS. The next day, cells were 
treated with a 4 Gy or remained untreated. At an indicated time point, 10 and 15 min after IR, 
cells were washed with PBS and fixed with 1 % PFA (fixing solution) (see section 2.9.3) for 
10 min at RT. Non-irradiated cells were included as a control. Cells were remained 
unpermeablized for staining the surface molecules. To block unspecific binding sites, cells 
were incubated with blocking buffer (see section 2.9.3) for 15 min at RT and incubated with 
anti-ASM antibody or anti-ceramide antibody for 60 min at RT. Cells were then washed once 
with PBS and stained with fluorescent-labeled secondary antibodies Cy3-anti-rabbit IgG or 
anti-mouse IgM, respectively in complete darkness. Cells were washed once with washing 
buffer (see section 2.9.3) for 5 min and incubated with 0.1µg/ml hoechst 33342 diluted in 
PBS for 15 min in darkness. Cells were finally washed two times with washing buffer once 
with PBS and embedded in mowiol. A Leica TCS SP confocal microscope was used for the 
fluorescence analysis of the cell surface molecules. 
To visualize the co-localized molecules, i.e. the clustering of gp91phox in ceramide-enriched 
membrane platforms on the plasma membrane of cells, every step was carried out as 
described above except for the different antibodies used. After blocking, cells were incubated 
with two different primary antibodies at a time, namely anti-ceramide antibody and anti-
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gp91phox antibody and incubated for 60 min at RT. Cells were washed once with PBS and 
incubated with Cy3-anti-mouse IgM for ceramide and FITC-anti-rabbit IgG for gp91phox, 
respectively in complete darkness. Cells were washed once with washing buffer for 5 min and 
incubated with 0.1µg/ml hoechst 33342 diluted in PBS for 15 min in darkness. Cells were 
finally washed two times with washing buffer, once with PBS and embedded in mowiol. A 
leica TCS SP confocal microscope was used for the fluorescence analysis of co-localizing 
molecules. 
For mitochondria and ceramide intracellular co-staining, cells were treated in the same way as 
mentioned above except that the cells were permeabilized using 0.1 % triton X-100 for 10 
min at RT. Cells were incubated with anti-TIMM23 and anti-ceramide primary antibodies 
followed with second antibodies Cy5-anti-rabbit IgG and Cy3-anti-mouse IgM respectively. 
All the steps after that were followed in the same way as above. 
 
3.7 DETERMINATION OF ROS BURST 
To measure ROS burst, cells were cultured in 96-well plates (2500 cells/well) and incubated 
with 10 μM H2DCFDA dissolved in DMSO for 10 min at 37°C. Cells were irradiated with 4 
Gy or remained untreated and the fluorescence was determined by fluorescence micro-plate 
reader at excitation/emission: 485/520 nm. ROS burst using ROS inhibitors was measured in 
the same way as mentioned except that the cells were pre-incubated with 100 μM of ROS 
inhibitors apocynin and tiron for 30 min at 37°C prior to addition of H2DCFDA and radiation 
treatment. 
 
3.8 SUPEROXIDE MEASUREMENT 
For measuring superoxide production, 2.0 x 106 cells were plated per round bottom 35 mm 
petri dish 24 h prior to irradiation. Cells were incubated with 5 μM DHE dissolved in PBS for 
5 min at 37°C followed by irradiation at a dose of 4 Gy. For control samples cells were loaded 
with DHE but remained non-irradiated. Immediately after irradiation images were taken 
starting from 1 min till 15 min using live cell imaging technique. 
For measuring mitochondrial ROS, cells were loaded with 10 μM MitoSOX dissolved in PBS 
for 20 min at 37°C and the procedure was followed exactly mentioned above. Images were 
taken after irradiation starting from 5 min till 20 min. 
 
 
  
56 METHODS 
3.9 NADPH ACTIVITY ASSAY 
To measure NADPH activity, cells were plated in 96 well-plates at a density of 2500 
cells/well 24 h prior to irradiation. Protocol was followed as mentioned by NADPH assay kit 
from sigma manufacturer (see section 2.7) with some changes. Next day medium was 
removed and 95 μl working solution+ 5 μl enzyme dilution buffer + 10 μl NADPH solution at 
a concentration of 0.85 mg/ml were added in each well. For each solution (see section 2.9.2). 
Cells were incubated for 15 min at RT followed by irradiation at a dose of 4 Gy. After 10 min 
absorbance was measured at 550 nm using micro-plate reader. For control samples similar 
procedure were carried except for the irradiation. 
 
3.10 WESTERN BLOTTING 
Cells at a density of 5.0 x 106 were plated in 60 mm petri dishes 24 h prior to the experiment. 
Cells were irradiated at a dose of 4 Gy except for the control which was remained non-
irradiated. After 10 and 15 min of IR, cells were washed once with cold PBS and lysed with 
500 µl SDS lysis buffer (see section 2.9.1) containing complete protease inhibitor cocktail. 
Cells were collected with the help of cell scraper and kept in microcentrifuge tubes further 
incubated on ice for 20 min to ensure complete lysis of cells. Cells were then centrifuged at 
800 x g for 10 min at 4°C. Cell lysates were collected as supernatant and the pellets were 
discarded. Protein concentration was measured from each lysates and samples were prepared 
by adding equal concentrations of lysates for each treatment plus SDS sample buffer (see 
section 2.9.1) in separate microcentrifuge tubes and boiled at 95°C for 5 min. If the sample 
was not used on the same day, it was kept at -20°C until further use. Each well of gel was 
loaded with 15-30 µg/µl protein samples. Proteins were separated using 10 % of sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to 
nitrocellulose membranes followed by blocking with blocking buffer (see section 2.9.1) for 60 
min at RT. After blocking, the membranes were incubated with primary antibody overnight at 
4°C. The next day, membranes were washed 2 x 10 min using washing buffer (see section 
2.9.1) and incubated 60 min with secondary antibody conjugated with horseradish peroxidase 
(HRP). Both primary and secondary antibodies were diluted in the respective antibodies 
dilution buffers (see section 2.9.1). Beta-actin was used to normalize the protein loading. To 
visualize the bands, enhanced chemiluminescence (ECL) immunoblotting substrate was used. 
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3.11 DOWNREGULATION OF gp91PHOX 
For transient transfection, 1.0x106 cells were seeded per well of a 6 well-plates with 2 ml 
culture medium. Cells were grown for 24 h to a confluence of about 60-70 %. Transfection 
procedure was performed according to manufacturer’s description (Qiagen) (see section 
2.2.3). Briefly, for each well two conditions were prepared namely control siRNA treated and 
gp91phox siRNA treated. For control siRNA treatment, 100 pmol of control siRNA already 
dissolved in RNase free buffer was added to the microcentrifuge tubes containing 100 µl of 
EC buffer. Similarly, for gp91phox siRNA treatment, 100 pmol of gp91phox siRNA 
dissolved in RNase free buffer was added to the microcentrifuge tubes containing 100 µl of 
EC buffer. Immediately after adding respective siRNA’s to the EC buffer, 3.5 µl of enhancer 
was added to each microcentrifuge tubes containing (EC buffer + siRNase). The mixture was 
vortexed for 1 sec and incubated for 5 min at RT followed by addition of 10 µl of effectene 
transfection reagent. The mixture (EC buffer + siRNase + enhancer + effectene transfection 
reagent) was vortexed for 10 sec and incubated for 15 min at RT. Culture medium (600 µl) 
were added to each mixture. Medium from the wells was removed and a fresh culture medium 
was added followed by the addition of mixture containing (EC buffer + siRNase + enhancer + 
effectene transfection reagent + culture medium). After 6 h of incubation the medium was 
removed from each well, washed one time with PBS followed by addition of 2 ml of fresh 
culture medium. After 48 h, culture medium was removed and cells were used for 
experiments. Transient downregulation of gp91phox was checked by western blotting. 
 
3.12 ISOLATION OF MITOCHONDRIA 
Mitochondria were isolated from the cells using thermo scientific mitochondria isolation kit 
(see section 2.7) and the procedure was carried out exactly in the same manner mentioned by 
the manufacturer. Briefly, 5.0 x 106 cells were plated per 100 mm petri dish 24 h prior to 
irradiation. Next day cells were irradiated with 4 Gy and for the control samples cells were 
remained non-irradiated. After 10 and 15 min of irradiation, medium was removed and cells 
were washed once with cold PBS, scraped and collected in microcentrifuge tube. Cell pellets 
were collected after centrifugation at 4°C, 500 x g for 5 min followed by addition of 800 μl 
mitochondria isolation reagent A. Samples were incubated for 2 min on ice, 10 μl 
mitochondria isolation reagent B was added and incubated 5 min on ice followed by vortexing 
every min. Similarly, 800 μl mitochondria isolation reagent C was added and the samples 
were centrifuged at 700 × g for 10 min at 4°C. Supernatant was collected and centrifuged at 
12,000 × g for 15 min at 4°C. Supernatant was discarded and the pellets were washed with 
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500 μl mitochondria isolation reagent C and finally centrifuged at 12,000 × g for 5 min at 
4°C. Mitochondrial pellets were collected and resuspended in 100 μl H2O and kept at -20°C 
until used. 
To confirm the isolation of mitochondria western blotting was done using Translocase Of 
Inner Mitochondrial Membrane 23 (TIMM23) antibody and for checking contamination, other 
organelle markers like alpha tubulin for cytoplasm, calnexin for ER and lysosomal-associated 
membrane protein 1 (Lamp-1) for lysosomes were used.  
 
3.13 DAG KINASE ASSAY FOR CERAMIDE QUANTIFICATION 
The principle of DAG kinase assay implies conversion of ceramide to ceramide-1-phosphate 
by the transfer of [32P]-phosphate from [32P]γ-ATP to ceramide. To quantify the ceramide 
production 2.0 x 106 cells/plate were seeded in a 35 mm petri dish 24 h prior to irradiation. 
The next day, cells were treated with a 4 Gy dose of IR; control cells remained non-irradiated. 
At an indicated time point, i.e. 10 and 15 min after IR, cells were washed with PBS and 
extracted in 500 μl of CHCl3: CH3OH: 1N HCl (100:100:1). The sample if not measured on 
the same day was kept at -20°C otherwise 100 μl of H2O was added per samples followed by 
centrifugation at maximum speed to visualize a clear separation of lower and upper phase. 
Three times 150 μl were taken from lower organic phase and concentrated by evaporation of 
the CHCl3 in a SpeedVac. Detergent solution (20 μl) (see section 2.9.2) was added to the 
evaporated lipids followed by sonication of the samples for 10 min in a bath sonicator in order 
to achieve formation of micelles. Reaction was started with addition of 70 μl of DAG-kinase 
reaction buffer (see section 2.9.2) and the samples were incubated for 60 min at RT on a 
thermomixer. The reaction was stopped by adding 1 ml of CHCl3:CH3OH:1N HCl 
(100:100:1, v/v/v) plus 170 μl of DAG-assay buffered saline solution (see section 2.9.2) and 
30 μl of a 100 mM EDTA solution per samples. Samples were vortexed and centrifuged at 
maximum speed. The lower organic phase were concentrated and dried in a SpeedVac. At the 
end 20 μl of CHCl3:CH3OH (1:1, v/v) was added to the dried lipids. Lipids were separated on 
a Silica G-60 TLC plate which was placed into the TLC chamber and the solvent containing 
CHCl3:CH3COCH3:CH3OH:CH3COOH:H2O (10:4:3:2:1, v/v/v/v/v). The TLC plate was then 
removed, air dried and ceramide was quantified using phosphorimager. 
 
 
 
  
59 METHODS 
3.14 IMMUNOPRECIPITATION (IP)  
For IP assay, 5.0 x 106 cells were plated per 100 mm petri dishes and kept in an incubator for 
24 h prior to the experiment. The next day, cells were irradiated at 4 Gy or remained 
untreated. After 10 and 15 min of IR, the medium was removed followed by washing once 
with cold PBS. Radioimmunoprecipitation assay buffer (RIPA) (see section 2.9.4) (900 µl) 
was used to lyse the cells, cell lysates were collected with a cell scraper and kept in 
microcentrifuge tubes on ice for 30 min for the complete lysis of cells. Non-irradiated cells 
were treated similarly. Lysates were then centrifuged for 5 min at 800 x g and 4°C. Pellets 
were discarded and supernatant were kept. From each tube i.e. 0 Gy, 4 Gy 10 min and 4 Gy 
15 min, 400 µl supernatant were added to separate microcentrifuge tubes. One out of each 
respective tube was used as control without adding antibody whereas to the other tubes, 1-2 
µg of antibody were added. Lysates with and without antibody were incubated for 4 h at 4°C 
under rotary agitation. Next, 25 µl Protein A/G PLUS-Agarose beads were added to the all the 
lysates and incubated for another 45 min at 4°C under rotary agitation. Lysates were 
centrifuged at 800 x g for 1 min at 4°C; proteins bound to beads were collected and the 
supernatant was discarded. Pellets were washed 5 times with RIPA buffer followed by a 
centrifugation at 800 x g for 1 min at 4°C. At the last wash step, the complete supernatant was 
removed, and 50 µl of RIPA lysis buffer were added to the pellet. Protein samples were 
prepared and analyzed by western blotting. Further samples were sent for MS analysis. 
 
3.15 CERAMIDE PULL-DOWN ASSAY 
Ceramide pull-down assay was performed following the detailed prescription given by the 
manufacturer Echelon Biosciences (see section 2.2.4). Briefly, 5.0 x 106 cells per 100 mm 
petri dish were plated 24 h before the experiment. The next day, cells were irradiated at the 
dose of 4 Gy or remained untreated; 10 and 15 min after IR, cells were washed once with 
PBS, and 900 µl of washing/binding buffer (see section 2.9.4) were added to each of the petri 
dish. Non-irradiated cells were treated similarly. Cell lysates were collected with a cell 
scraper and centrifuged for 5 min at 800 x g at 4°C. Pellets were discarded and supernatant 
were kept. From each tube, i.e. 0 Gy, 4 Gy 10 min and 4 Gy 15 min, 400 µl supernatant were 
added to a new microcentrifuge tubes. One out of each respective tube was used as control by 
addition of 20 µl control beads whereas to the other tubes, 20 µl ceramide beads were added. 
Lysates and beads were incubated for 4 h at 4°C under rotary agitation followed by 
centrifugation at 400 x g for 5 min at 4°C. Supernatant were discarded and the pellets 
containing beads were washed with 200 µl washing/binding buffer and centrifuged at 400 x g 
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for 5 min at 4°C and this procedure was done for 5 times. At the last washing step, complete 
supernatant was removed and beads were suspended with 50 µl of washing/binding buffer and 
kept at -80°C until use. Samples were sent for MS analysis. 
 
3.16 LIPID RAFT ISOLATION USING SUCROSE DENSITY GRADIENT 
CENTRIFUGATION 
Cells were plated at a density of 5.0 x 106 per 100 mm petri dish 24 h prior to the experiment. 
The next day, cells were irradiated at 4 Gy or remained untreated, and at 10 and 15 min after 
IR, the medium was removed followed by washing the cells with cold PBS. PBS was 
completely removed and 1 ml of 500 mM Na2CO3 was added to each 100 mm dish. Cells 
were scraped and transferred to a dounce (glass-glass) homogenizer and homogenized with 60 
strokes on ice. Control samples remained non-irradiated were also treated in same way. 
Lysate were transferred to microcentrifuge tubes and sonicated for 30 sec for three times with 
tip sonicator using intervals of 100 sec in between. Finally, 1 ml of cell lysates was mixed 
with 1 ml 90 % sucrose of which 1.3 ml (mixture of cell lysates plus 90 % sucrose) was 
layered in a Beckman ultracentrifuge tube followed by 1.3 ml 35 % sucrose layering and 0.6 
ml 5 % sucrose with a total volume of 3.2 ml. For sucrose % (see section 2.9.4). A visible 
interface between the two density layers should be seen. Ultracentrifugation was performed 
for 24 h at 240,000 x g and 4°C in a TLA-55 rotor. After the centrifugation a faint band 
consisting of the buoyant lipid raft was visible between the 35 % and the 5 % sucrose 
interface. A volume of approximately 1 ml was collected and stored until use at -80°C. 
Isolation of lipid rafts was confirmed by western blotting. Further samples were sent for MS 
analysis. 
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4 RESULTS 
 
4.1 IONIZING RADIATION (IR) INDUCES DOSE- AND TIME-DEPENDENT CELL 
DEATH 
To determine dose-and time-dependent cell death of two human glioblastoma cell lines A172 
and LN308, two different conditions were used. For dose-dependent analysis of cell death, 
cells were irradiated with different doses (0, 2, 4, 6, 8 Gy). Cells were harvested and stained 
with propidium iodide (PI) after 96 h. Similarly, for analysis of time-dependent cell death, 
cells were irradiated with a single dose of 4 Gy or left untreated and after 72, 96 and 120 h 
cells were stained with PI. In both experiments cells were stained with PI which is not able to 
pass intact cell membranes and PI positive cells were therefore considered to be the dead 
cells. The results revealed significant increase in cell death in both dose- and time-dependent 
manner when compared to non-irradiated cells, i.e. 0 Gy.  
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Figure 4.1: Dose- and time-dependent cell death upon IR 
Cells were treated with different doses and after 96 h cells were stained with PI for dose 
dependent response (a) A172 and (b) LN308. Similarly cells were irradiated with a single 
dose of 4 Gy and after irradiated time point cells were stained with PI for time-dependent 
response (c) A172 and (d) LN308. Cell death was determined by FACS analysis using FL-2 
channel. The data given are the mean values ± S.D. of 3 independent experiments.  
Statistical significance between non-irradiated and irradiated cells was determined by analysis 
of variance (ANOVA) followed by a Bonferroni’s selected comparisons test. P-values 
(p≤0.05, p≤0.01, p≤0.001) are indicated by an asterisk* or** or ***, respectively. 
 
4.2 ACTIVATION OF ASM UPON IR 
Many stress stimuli like bacterial infection (Grassmé et al 2003b, Zhang et al 2008), death 
receptors (Cifone et al 1994, Cremesti et al 2001, Perrotta et al 2010), oxidative stress (Li et al 
2012, Zhang et al 2007), UV-light (Charruyer et al 2005, Kashkar et al 2005, Rotolo et al 
2005, Zhang et al 2001), including irradiation (Paris et al 2001, Santana et al 1996, 
Sathishkumar et al 2005) are known to induce activation of ASM in variety of cell types 
leading to cell death pathways. To investigate whether IR is involved in inducing the 
activation of ASM in human glioblastoma cells, cells were irradiated with 4 Gy or remained 
untreated and after 10 and 15 min the enzymatic activity of ASM was measured. For A172 
cells around 5-10 µg and for LN308 cells around 10-15 µg of proteins per samples were used 
to measure the ASM activity. The result showed a rapid activation of ASM in both cell lines 
after irradiation (Figure 4.2). At 10 min after irradiation, a transient increase in ASM activity 
is seen with slight decrease after 15 min in A172 cell lines. However, when compared to 0 Gy 
both 10 and 15 min irradiated cells showed an increase in ASM activity in both the cell lines. 
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Figure 4.2: IR activates ASM 
A172 (a) and LN308 (b) human glioblastoma cells were irradiated with 4 Gy or left untreated. 
The activity of the ASM was measured as the consumption of radioactive [14C]sphingomyelin 
to ceramide and [14C]phophorylcholine. The data given are the mean values ± S.D. of 3 
independent experiments.  
Statistical significance between non-irradiated and irradiated cells was determined by analysis 
of variance (ANOVA) followed by a Bonferroni’s selected comparisons test. P-values 
(p≤0.05, p≤0.01) are indicated by an asterisk* or**, respectively. 
 
4.3 IR-INDUCED TRANSLOCATION OF ASM FROM INTRACELLULAR PART TO 
OUTER LEAFLET OF CELLS 
To analyze whether the observed ASM activation in the human glioblastoma cell lines is 
accompanied by translocation of the ASM to the outer leaflet of the cell membrane, cells 
grown on coverslips were irradiated with 4 Gy or left non-irradiated. After 10 and 15 min, 
cells were fixed and stained with an antibody specific for the ASM. The result showed ASM 
translocation to the cell surface/outer leaflet in irradiated cells while no translocation of ASM 
was observed in non-irradiated cells (Figure 4.3). 
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Figure 4.3: Translocation of ASM from intracellular part to outer leaflet of cells upon 
IR  
Human glioblastoma cell lines A172 (a) and LN308 (b) were irradiated with 4 Gy or left 
untreated. Cells were remained unpermeabilized and stained with anti-ASM antibody 
followed by Cy3-labeled anti-rabbit secondary antibody. The nuclei were stained with 
Hoechst 33342; the merge picture panel shows the overlay of Hoechst 33342 and ASM/Cy3. 
The transmission light picture was taken in addition. The images are representative for 3 
independent studies. 
 
4.4 CLUSTERING OF CERAMIDE/CERAMIDE-ENRICHED MEMBRANE 
PLATFORMS UPON IR  
Activation of ASM has been correlated with release of ceramide and formation of ceramide-
enriched membrane platforms upon different stimuli. To study whether IR mediates clustering 
of ceramide/ceramide-enriched membrane platforms, human glioblastoma cell lines A172 and 
LN308 were remained non-irradiated or irradiated with 4 Gy. After 10 and 15 min, cells were 
fixed and immunofluorescence staining was carried out using a monoclonal anti-ceramide 
antibody (MID15B4) followed by a Cy3-labeled anti-mouse secondary antibody. The result 
revealed that ceramide accumulates in the platforms on the cell surface of both cell lines after 
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irradiation leading to clustering of ceramide (Figure 4.4), whereas no clustering was seen in 
non-irradiated cells.  
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Figure 4.4: IR induces clustering of ceramide and formation of ceramide-enriched 
membrane platforms 
Human glioblastoma cell lines A172 (a) and LN308 (b) were irradiated with 4 Gy or remained 
untreated. Cells were remained unpermeabilized and stained with anti-ceramide antibody 
(MID15B4) followed by Cy3-labeled anti-mouse secondary antibody. The nuclei were stained 
with Hoechst 33342; the merge picture panel shows the overlay of Hoechst 33342 and 
ceramide/Cy3. The transmission light picture was taken in addition. The images are 
representative for 3 independent studies. 
 
4.5 ROS IS NECESSARY FOR IR-INDUCED ACTIVATION OF ASM 
Previous studies have shown the role of ROS in activation of ASM in T splenocytes and 
macrophages (Dumitru and Gulbins 2006, Zhang et al 2008). Since IR is known to be an 
inducer of ROS production, it was tested whether IR-induced ROS production triggered ASM 
activation. To determine the ROS burst in human glioblastoma cell lines A172 and LN308, 
cells were pre-incubated for 10 min with 2',7'-dichlorodihydrofluorescein diacetate 
(H2DCFDA), a cell-permeant fluorogenic dye that measures ROS by passively diffusing into 
the cells. H2DCFDA is retained in the intracellular level after cleavage by intracellular 
esterases. The nonfluorescent H2DCFDA is then converted to the highly fluorescent 2',7'-
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dichlorofluorescein (DCF). Cells were remained untreated or treated with 4 Gy. IR-induced 
an increase of ROS burst in irradiated cells compared to non-irradiated cells. Similarly ROS 
production was also measured by incubating the cells with ROS inhibitors apocynin and tiron, 
which significantly attenuated IR–induced ROS production (Figure 4.5 a and b). Tiron is a 
ROS scavenger whereas apocynin is known to be an inhibitor of nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase activity. Apocynin inhibits the assembly of a 
functional NADPH-oxidase complex that is responsible for ROS production upon oxidation 
by myeloperoxidase (Touyz 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To analyse whether ROS mediates IR-induced activation of ASM, enzymatic activity of ASM 
was measured in human glioblastoma cell lines A172 and LN308. Cells were incubated with 
the ROS inhibitors apocynin and tiron prior to the 4 Gy dose of radiation treatment. This 
resulted in an inhibition of IR-induced ASM activation, which shows the pivotal role of ROS 
in the ASM activation mechanism (Figure 4.5 c and d) 
0G
y
0G
y+
ap
oc
yn
in
0G
y+
tir
on
4G
y,
 1
0m
in
4G
y,
 1
0m
in
+a
po
cy
ni
n
4G
y,
 1
0m
in
+t
iro
n
0
2000
4000
6000 ***


(a) A172
R
O
S
 p
ro
d
u
c
ti
o
n
(D
C
F
 f
lu
o
re
s
c
e
n
c
e
)
0G
y
0G
y+
ap
oc
yn
in
0G
y+
tir
on
4G
y,
 1
0m
in
4G
y,
 1
0m
in
+a
po
cy
ni
n
4G
y,
 1
0m
in
+t
iro
n
0
2000
4000
6000
8000
***

(b) LN308
R
O
S
 p
ro
d
u
c
ti
o
n
(D
C
F
 f
lu
o
re
s
c
e
n
c
e
)
  
69 RESULTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: IR-induced activation of ASM is ROS dependent 
Human glioblastoma cell lines A172 (a) and LN308 (b) were incubated with ROS inhibitors 
apocynin and tiron followed by further incubating the cells with H2DCFDA. Cells were 
irradiated with 4 Gy or remained untreated and ROS was measured after 10 min using micro-
plate reader. A172 (c) and LN308 (d) were incubated with ROS inhibitors apocynin and tiron 
followed by treating the cells with 4 Gy or remained untreated. Activity of ASM was 
determined as the consumption of radioactive [14C]sphingomyelin to ceramide and 
[14C]phophorylcholine. The data given are the mean values ± S.D. of 3 independent 
experiments. 
Statistical significance between non-irradiated and irradiated cells was determined by analysis 
of variance (ANOVA) followed by a Bonferroni’s selected comparisons test. P-values 
(p≤0.05, p≤0.01, p≤0.001) are indicated by an asterisk* or** or *** respectively or irradiated 
and ROS inhibitos/irradiated are indicated by delta Δ or ΔΔ or ΔΔΔ, respectively. 
 
4.6 ACTIVATION OF ASM AND FORMATION OF CERAMIDE-ENRICHED 
MEMBRANE PLATFORMS UPON IRRADIATION IS DEPENDENT ON NADPH 
OXIDASE  
4.6.1 IR INDUCES ACTIVATION OF NADPH OXIDASE AND SUPEROXIDE 
PRODUCTION 
Previous studies have shown NADPH oxidase subunits to aggregate into ceramide-enriched 
membrane platforms producing superoxide to regulate signaling process (Jin et al 2008c, 
Zhang et al 2006). Similarly it has also been reported that radiation-induced oxidative stress is 
mediated by NADPH oxidase (Collins-Underwood et al 2008).  
This led us to examine whether IR is involved in aggregation of gp91phox, a major membrane 
subunit of NADPH oxidase into ceramide-enriched membrane platforms. 
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IR-induced activation of NADPH oxidase was assayed by cytochrome c reduction in A172 
cells. The assay mixtures consisted of cytochrome c, enzyme dilution buffer and NADPH 
solution (see materials). Cells were incubated with the assay mixtures for 15 min at RT 
followed with irradiation with 4 Gy or remained untreated. After 10 min total NADPH 
activity was measured at an absorbance of 550 nm using micro-plate reader. The results 
revealed 20 % increase in activation of NADPH oxidase in irradiated cells when compared to 
non-irradiated cells (Figure 4.6.1 a). As NADPH oxidase is a major source of superoxide 
production, next superoxide production was measured in human glioblastoma cell line A172 
using dihydroethidium (DHE), a molecular probe for superoxide measurement. The substance 
DHE detects ROS and upon reaction with superoxide anions forms a red fluorescent product 
(ethidium) which intercalates with DNA. Cells were incubated for 5 min with DHE and 
remained non-irradiated or irradiated at a dose of 4 Gy. Superoxide production was monitored 
using a live cell imaging technique and images were taken starting from 1 min till 15 min. For 
this experiment, special round bottom petri dishes were used. The results showed increase in 
the fluorescence intensity for DHE dye in irradiated cells in time-dependent manner whereas 
no increase in the fluorescence intensity was observed in non-irradiated cells (Figure 4.6.1 b). 
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Figure 4.6.1: Increase in activation of NADPH oxidase and superoxide production upon 
IR 
NADPH oxidase activity was measured in A172 cells by incubating the cells with cytochrome 
c and NADPH solution. After 15 min of incubation cells were irradiated with 4 Gy or 
remained untreated. The data given are the mean values ± S.D. of 3 independent experiments 
performed in triplicate.  
Significant differences (p≤0.05, t-test) between non-irradiated and irradiated cells are labeled 
by an asterisk*. 
Human glioblastoma cell line A172 (b) were incubated with DHE to measure superoxide and 
fluorescence intensity was recorded using live cell imaging technique. The images are 
representative for 3 independent studies. 
 
4.6.2 IR-INDUCED ACTIVATION OF NADPH OXIDASE VIA CERAMIDE-ENRICHED 
MEMBRANE PLATFORMS 
The role of ceramide-enriched membrane platforms in signaling pathway was fully elucidated 
showing that these platforms trap and cluster death receptors like CD95 and CD40 (Cremesti 
et al 2001, Grassmé et al 2001a, Grassmé et al 2001b, Grassmé et al 2002a). As a result of this 
trapping and clustering of receptors cell death signal is transmitted inside of the cells. Later 
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on, other signaling molecules like subunits of NADPH oxidase particularly gp91phox and 
p47phox were shown to be clustered in ceramide-enriched membrane platforms resulting in 
activation of ASM in endothelial cells (Bao et al 2010, Zhang et al 2007). To address the 
mechanism of IR-induced activation of NADPH oxidase with the involvement of ceramide-
enriched membrane platforms, it was examine whether ceramide-enriched membrane 
platforms are involved in aggregation of gp91phox, a major membrane subunit of NADPH 
oxidase. Immunofluorescence co-staining of ceramide and gp91phox was performed. Human 
glioblastoma cell lines A172 and LN308 were remained non-irradiated or irradiated with 4 
Gy. After 10 and 15 min, cells were fixed and remained unpermeabilized followed by staining 
the cells with monoclonal anti-ceramide antibody (MID15B4) and gp91phox antibody. 
Similarly, Cy3-labeled anti-mouse and FITC- labeled anti-rabbit secondary antibodies were 
used. The results showed that gp91phox aggregates/clusters in and co-localizes with 
ceramide-enriched platforms (Figure 4.6.2) and this phenomenon was absent in non-irradiated 
cells. 
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Figure 4.6.2: NADPH oxidase subunit gp91phox clusters in ceramide-enriched 
membrane platforms upon irradiation 
Human glioblastoma cell lines A172 (a) and LN308 (b) were irradiated with 4 Gy or left 
untreated and fixed. Cells were remained unpermeabilized and stained with anti-ceramide 
(MID15B4) and gp91phox antibodies followed by Cy3-labeled anti-mouse and FITC-labeled 
anti-rabbit secondary antibodies. The nuclei were stained with Hoechst 33342; the merge 
picture panel shows the overlay of ceramide/Cy3 and gp91phox/FITC. The transmission light 
picture was taken in addition. The images are representative for 3 independent studies. 
 
4.6.3 INVOLVEMENT OF GP91PHOX IN IR-INDUCED ACTIVATION OF ASM 
Previously it was shown that adipokines (visfatin), a Pre-B colony Enhancing Factor (PBEF) 
known to be involved in the early development of B lymphocytes (Samal et al 1994) 
stimulates ceramide production via activation of ASM and induces NADPH oxidase 
activation through the formation of lipid raft (LR) signaling platforms in glomerular 
endothelial cells (GECs). Silencing of ASM gene or using ASM inhibitor amitriptyline or 
silencing of gp91phox gene or using NADPH oxidase inhibitor, diphenyleneiodonium 
chloride (DPI) attenuated the co-localization of gp91phox and LR showing the existence of 
feed forward loop. Thus, the study elucidated the role of ASM to form redox signaling 
platforms by aggregation and activation of NADPH oxidase subunits gp91phox (Boini et al 
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2010). Similarly Zhang and coworker showed using NADPH oxidase inhibitor DPI resulted 
in blockade of Asm activation and formation of ceramide-enriched membrane platforms in 
macrophages upon P. aeruginosa stimulation (Zhang et al 2008). 
To explore the involvement of gp91phox upon activation of ASM during radiation, one of the 
human glioblastoma cell lines A172 were transfected with either gp91phox siRNA or control 
siRNA. The result demonstrated that transfecting the cells with gp91phox siRNA for 48 h 
resulted in around 50 % downregulation of gp91phox protein expression which was 
confirmed by western blotting using antibody against gp91phox (Figure 4.6.3 a). 
Normalization of control siRNA and gp91phox siRNA with loading control beta-actin was 
carried out using imageJ program (Figure 4.6.3 b). Further enzymatic activity of ASM was 
measured in gp91phox as well as control siRNA transfected cells which was treated with 4 Gy 
or remained untreated. This result showed inhibition of ASM activity in gp91phox siRNA 
transfected cells compared to control siRNA transfected cells upon irradiation (Figure 4.6.3c).  
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Figure 4.6.3: IR induced activation of ASM is NADPH oxidase dependent  
A172 cells were transfected with control or gp91phox siRNA followed by western blotting to 
confirm the downregulation of gp91phox protein (65 kDa) (a).  
The images are representative for 2 independent studies. 
Normalization of gp91phox and control siRNA transfected protein level to loading control 
beta-actin was confirmed using program imageJ (b). A172 cells were transfected with 
gp91phox and control siRNA followed with 4 Gy dose of irradiation or remained untreated. 
ASM activity was measured as the consumption of radioactive [14C]sphingomyelin to 
ceramide and [14C]phophorylcholine (c). The data given are the mean values ± S.D. of 3 
independent experiments. 
Statistical significance between non-irradiated (control siRNA) and irradiated (control 
siRNA) or irradiated (control siRNA) and irradiated (gp91phox siRNA) was determined by 
analysis of variance (ANOVA) followed by a Bonferroni’s selected comparisons test. P-
values (p≤0.05, p≤0.001) between non-irradiated (control siRNA) and irradiated (control 
siRNA) are indicated by an asterisk* or *** and irradiated (control siRNA) and irradiated 
(gp91phox siRNA) are indicated by delta Δ respectively. 
 
4.7 MITOCHONDRIAL ROS AND CERAMIDE PRODUCTION IN IRRADIATED 
HUMAN GLIOBLASTOMA CELLS 
Several studies have shown the role of radiation in production of mitochondrial ceramide 
leading to cell death (Dai et al 2004, Lee et al 2011). To investigate whether IR targets 
organelles other than plasma membrane for generation of ceramide/ceramide-enriched 
membrane platforms upon irradiation in human glioblastoma cell lines, studies targeting 
mitochondria was performed. Mitochondrial ROS was measured in A172 cells using 
MitoSOX red, a mitochondrial superoxide indicator. MitoSOX red is a fluorogenic dye that 
targets mitochondria as it can permeates live cells. It is rapidly oxidized by superoxide and 
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upon binding to nucleic acid the oxidized product is highly fluorescent. Irradiating the cells 
with 4 Gy in presence of MitoSOX for 20 min resulted in rapid production of mitochondrial 
superoxide. Images were taken through live cell imaging technique starting from 5 min till 20 
min which showed a time-dependent ROS increase in irradiated cells. No such increase was 
observed in non-irradiated cells (Figure 4.7 a). Next a co-staining of ceramide and 
mitochondrial marker TIMM23 was performed. For this A172 cells were remained non-
irradiated or irradiated with 4 Gy and after 10 and 15 min, cells were fixed and permeabilized. 
Cells were stained with monoclonal anti-ceramide (MID15B4) and TIMM23 antibodies 
followed by Cy3-labeled anti-mouse and Cy5-labeled anti-rabbit antibodies. The result 
revealed the co-localization of ceramide in mitochondria in irradiated cells. Compared to the 
irradiated cells no co-localization was seen in non-irradiated cells (Figure 4.7 b).  
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To make a quantitative analysis for mitochondrial ceramide production, diacylglycerol (DAG) 
kinase assay in mitochondrial-enriched fractions isolated from human glioblastoma A172 and 
LN308 cells was performed. For this, human glioblastoma cell lines A172 and LN308 were 
irradiated with 4 Gy or remained untreated and after 10 and 15 min cells were collected. 
Mitochondria were isolated using mitochondrial isolation kit (see materials). Western blotting 
was used to confirm enrichment of mitochondria using mitochondrial marker TIMM23. 
Similarly, to verify that the isolated mitochondrial fractions are free from contaminations 
various other organelles markers like alpha-tubulin for cytoplasm, calnexin for endoplasmic 
reticulum (ER) and lysosomal-associated membrane protein 1 (Lamp-1) for lysosomes were 
used. As a result, isolated mitochondrial fractions were found to be negative when tested with 
all the other organelle markers except for ER marker calnexin, which showed a slight band 
positive for isolated fractions within the mitochondrial fraction (Figure 4.7 c and d). Once 
isolated mitochondrial fractions were confirmed, ceramide DAG-kinase assay was performed 
in those fractions. Ceramide (C16 and C24 species) was separated from other lipids with the 
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use of thin-layer chromatography (TLC) (Figure 4.7 e and f). Quantification of TLC plates 
was performed using phosphorimager (Fujifilm) (Figure 4.7. g and h). 
Results from scanned TLC plates showed a small increase in ceramide level at 10 and 15 min 
after irradiation in both cell lines when compared to non-irradiated cells. Despite ceramide 
increase was clearly visible, it has to be mentioned that after quantification of ceramide levels 
the increase was not statistically significant. The next point to be noticed would be that a clear 
increase of mitochondrial ceramide is observed in fluorescence microscopy with a very less 
amount of ceramide seen in non-irradiated cells because the setting for microscope were 
minimized to see if there is any difference between irradiated and non-irradiated cells. The 
settings were kept exactly the same for both the treated as well as non-irradiated samples. The 
results from DAG kinase assay might be the ceramide from mitochondria as well as ER as 
contamination in isolated mitochondrial fractions was observed. 
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Figure 4.7: IR results in production of mitochondrial ROS and ceramide 
Human glioblastoma cells A172 (a) were irradiated with 4 Gy or remained non-irradiated in 
presence of mitochondrial indicator MitoSOX. Live cell imaging technique was used to 
monitor the mitochondrial ROS production. The transmission light picture was taken in 
addition. The images are representative for 3 independent studies. 
Co-staining for ceramide and mitochondria in untreated and irradiated A172 cells (b) were 
performed using antibodies against ceramide and mitochondria (TIMM23) followed by Cy3- 
labeled anti-mouse and Cy5-labeled anti-rabbit antibodies. To view intracellular ceramide, 
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cells were fixed and permeabilized. The nuclei were stained with Hoechst 33342; the merge 
picture panel shows the overlay of ceramide/Cy3 and TIMM23/Cy5. The images are 
representative for 3 independent studies.  
Isolation of mitochondrial fraction in A172 (c) and LN308 (d) cells were analyzed by western 
blotting with antibody to TIMM23 (mitochondria marker) 22 kDa and contamination was 
checked with antibodies to alpha tubulin (cytoplasm marker) 50 kDa, calnexin (ER marker) 
90 kDa and Lamp-1 (lysosomes marker) 120 kDa. The images are representative for 3 
independent studies. 
Human glioblastoma cell lines A172 (e) and LN308 (f) were treated with 4 Gy or remained 
untreated and cellular ceramide was determined by DAG-kinase assay. The assay is used to 
determine the cellular ceramide amount by the phosphorylation of ceramide to ceramide-1-
phosphate in the presence of [32P]γ-ATP. The TLC shows the C16 and C24 species of 
ceramide. The images are representative for 3 independent studies. 
 
4.8 IDENTIFICATION OF VARIOUS INTERACTING PARTNERS OF ASM, 
CERAMIDE AND LIPID RAFT AFTER IR 
Although a massive knowledge about ASM/ceramide-regulated pathways has increased in the 
past decade, molecular mechanisms of ASM/ceramide action remain poorly understood, 
primarily due to limited information about ASM/ceramide-binding proteins. In the present 
study, liquid chromatography–mass spectrometry/mass spectrometry (LC-MS/MS) was used 
to identify potential ASM/ceramide-interacting proteins in A172 human glioblastoma cells. In 
addition lipid raft-binding proteins were also identified. First, to identify ASM interacting 
proteins, human glioblastoma cells A172 and LN308 were irradiated with 4 Gy or remained 
untreated. After 10 and 15 min cells were lysed and ASM (65 kDa) was immunoprecipitated 
using protein A/G PLUS-Agarose beads. Immunoprecipitation results was confirmed by 
western blotting using ASM antibody (Figure 4.8 a and b). The samples from A172 cells were 
further subjected to LC-MS/MS. The purification resulted in identification of different 
proteins. One of the most important proteins found in 10 min irradiated samples was flotillin-
1. Flotillin-1 is a subtype of flotillins which are categorized as plasma membrane proteins 
forming detergent-resistant domains known as lipid raft. No flotillin-1 protein was present in 
non-irradiated samples. Similarly various cytoskeleton proteins namely desmocollin-3, f-
actin-capping protein subunit alpha-2, talin-1 was also identified in irradiated samples. 
To identify proteins interacting with ceramide in A172 cells, cells were irradiated with 4 Gy 
or remained untreated. After 10 and 15 min, cells were lysed and ceramide was pulled down 
using ceramide beads. To prove non-specific binding of beads to lysates, samples with control 
beads were also included. Samples were further subjected to LC-MS/MS. As a result, 
different proteins were identified. The identified proteins are known to be involved in various 
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cellular processes including apoptosis, cellular stress, cell cycle, cell differentiation and 
signaling. One of the important proteins identified in 15 min irradiated samples was caveolin-
1. Caveolin-1 is known to play an important role in cell growth by modulating the activity of 
various molecules involved in growth factor signaling (Shack et al 2003). Caveolin-1 is 
known to be a tumor suppressor protein that inactivates several signaling molecules involved 
in survival pathways by interacting with them. No caveolin-1 protein was present in non-
irradiated samples.  
 
For determination of proteins interacting with lipid rafts, isolation of lipid rafts was performed 
with A172 and LN308 cells using sucrose density gradient technique. Cells were irradiated 
with 4 Gy or remained untreated. After 10 and 15 min cells were lysed and homogenized with 
60 strokes in a dounce homogenizer. A layer of sucrose and samples was loaded in centrifuge 
tube. The sucrose gradient samples were spun for 24 h and lipid raft fractions were harvested 
by collecting 0.5 ml fractions, beginning at the top of the gradient. Isolated lipid raft was 
confirmed by western blotting using antibody against flotillin-1 (47 kDa), a marker for lipid 
raft. The results showed a clear band positive for flotillin-1 (Figure 4.8 c and d). To be sure 
that the isolated fractions were free of contamination, mitochondrial marker COXIV (17 kDa) 
was used and by western blotting it was revealed that the fraction was negative for COXIV 
(Figure 4.8 e and f). The samples from A172 cells were further subjected to LC-MS/MS and 
more than 500 different proteins were identified. Since caveolins and flotillins are known to 
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be lipid raft proteins, caveolin-1 and flotillin-1, 2 proteins were identified in both irradiated 
and non-irradiated samples. Various proteins involved in lysosomal trafficking of ASM 
namely dysferlin (Han et al 2012) and sortilin (Jin et al 2008b) were also identified in 
irradiated samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: Confirmation of ASM immunoprecipitation and lipid raft isolation 
Human glioblastoma cells A172 (a) and LN308 (b) were irradiated with 4 Gy or left non-
irradiated for immunoprecipitation of ASM. Cells were incubated with protein A/G PLUS-
Agarose beads and ASM antibody. The results were confirmed by western blotting.  
The images are representative for 3 independent studies. 
For isolation of lipid rafts, human glioblastoma cell lines A172 (c) and LN308 (d) cells were 
irradiated with 4 Gy or left untreated followed by sucrose density gradient technique. To 
confirm that the isolation of lipid rafts, western blotting was performed using lipid raft marker 
flotillin-1 (47 kDa) and the fraction was found to be positive for this marker (e). To check if 
the lipid raft fractions were free of contamination, the same blot already checked before for 
flotillin-1 was probed with antibody against mitochondrial marker COXIV (17 kDa) in A172 
and LN308 (f) which was found to be negative. The images are representative for 3 
independent studies.  
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5 DISCUSSION 
5.1 ACTIVATION AND TRANSLOCATION OF ASM  
ASM activity can be measured in cells lysates by radioactively or fluorescently 
sphingomyelin labeled. ASM activity assay using radioactive [14C]sphingomyelin is measured 
as a rate of consumption of [14C]sphingomyelin to ceramide and [14C]phosphorylcholine. 
Ceramide being insoluble in water remains in lower organic phase whereas 
[14C]phosphorylcholine being easily soluble in water is separated from the substrate 
[14C]sphingomyelin and ceramide. For three forms i.e. acid, neutral and alkaline, 
sphingomyelin serves as a substrate (Hannun 1996). Another method for measuring ASM 
activity is fluorescence-based, high-performance liquid chromatographic assay (He et al 2002, 
He et al 2003) where sphingomyelin is hydrolyzed to phosphorylcholine and ceramide in 
presence of sphingomyelinase. Dephosphorylation of phosphorylcholine by alkaline 
phosphatase results in generation of choline which is used for production of hydrogen 
peroxide. The reaction is catalyzed by enzyme choline oxidase. Hydrogen peroxide then 
reacts with amplex red reagent after addition of peroxidase resulting in a fluorescent product 
(He et al 2002).  
In the present study ASM enzymatic activity was measured as the consumption of radioactive 
[14C]sphingomyelin to ceramide and phosphorylcholine. Two different human glioblastoma 
cell lines A172 and LN308 were remained untreated or treated with 4 Gy. Transient activation 
of ASM within 10 and 15 min after irradiation was observed. Our results relates to some of 
the earlier findings which showed irradiation induces activation of ASM in different cell types 
(Paris et al 2001, Santana et al 1996, Sathishkumar et al 2005). To check if ASM activation is 
accompanied by its translocation to the outer leaflet of the cell membrane as shown in 
different studies (Grassmé et al 2001a, Perrotta et al 2010), immunofluorescence staining was 
performed. Cells were remained unpermeabilized to view ASM in plasma membrane before 
and after 4 Gy. Result showed that ASM was translocated to the plasma membrane of 
irradiated cells whereas no such translocation was observed in non-irradiated cells. ASM is 
known to be activated upon various stress stimuli for example upon bacterial infection 
(Grassmé et al 2003b, Zhang et al 2008), death receptors (Cifone et al 1994, Cremesti et al 
2001, Grassmé et al 2001a, Perrotta et al 2010) oxidative stress (Li et al 2012, Zhang et al 
2007), UV-light (Charruyer et al 2005, Kashkar et al 2005, Rotolo et al 2005, Zhang et al 
2001), irradiation (Paris et al 2001, Santana et al 1996, Sathishkumar et al 2005). Activation 
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of ASM has been correlated with its translocation from lysosome to plasma membrane 
(Grassmé et al 2001a, Perrotta et al 2010). Lymphocytes stimulated with CD95 resulted in 
translocation of ASM to the outer surface of plasma membrane. Further clustering of CD95 in 
sphingolipid-rich membrane rafts was also observed leading to apoptosis induction whilst 
ASM-deficient lymphocytes prevented CD95 clustering and apoptosis upon stimulation. 
Translocation of ASM onto the cell surface upon CD95 stimulation was detected using 
confocal as well as scanning electron microscopy and the activity of ASM was measured 
using radioactive method (Grassmé et al 2001a). In human glioma cells U373, ASM activated 
and translocated upon CD95-activating antibodies CH11 stimulation. Activation of ASM 
within 5 min of treatment was observed and around 30 min the condition returned to control 
level. Activity of ASM was measured by radioactive technique whereas for translocation of 
ASM, three different techniques were used: cell surface biotinylation assay, flow cytometry 
and immunofluorescence. ASM translocation upon CD95 treatment was found to be 
dependent on SNARE (soluble N-ethylmaleimide-sensitive-factor activating protein receptor) 
protein syntaxin 4 (Perrotta et al 2010). 
 
5.2 MECHANISM OF THE ASM ACTIVATION 
In this study it was shown that IR-induced a rapid activation of ASM in human glioblastoma 
cells A172 and LN308 which was found to be dependent on ROS production, since inhibition 
of ROS using two different ROS inhibitors apocynin and tiron prevented the activation of 
ASM. It should be mentioned that apocynin and tiron did not completely block ASM 
activation because of incomplete block of ROS. Our results relates to the finding from 
Dumitru and colleagues where using ROS inhibitors tiron and N-acetyl cysteine prevented 
activation of ASM upon TNF-related apoptosis-inducing ligand (TRAIL) stimulation 
(Dumitru and Gulbins 2006). Similarly upon Pseudomonas aeruginosa (P. aeruginosa) 
infection in macrophages, ROS scavengers were able to block activation and translocation of 
ASM further blocking formation of ceramide-enriched membrane platforms (Zhang et al 
2008). In neutrophils ceramide derived from ASM was found to be mediated by ROS which 
further resulted in CD95 clustering finally leading to apoptosis (Scheel-Toellner et al 2004). 
Not only the role of ROS in ASM activation has been studied but some findings have shown 
that ROS mediates the translocation and activation of ASM at the plasma membrane. Studies 
with U937 cells showed ROS regulated activation and translocation of ASM to membrane 
rafts resulting in ceramide-enriched membrane platforms formation and this event was 
blocked using ROS scavengers pyrrolidinedithiocarbamate (PDTC) (Charruyer et al 2005). 
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Similarly, Jurkat cells when stimulated with hydrogen peroxide showed activation and 
translocation of ASM to membrane rafts (Li et al 2012). Some of the studies have 
demonstrated that ASM once activated can plays a crucial role in production of ROS showing 
the existence of a feed forward loop between ROS and ASM. Using ASM inhibitors on 
hepatocytes resulted in blockade of ROS production (Reinehr et al 2005). Studies on 
macrophages and endothelial cells revealed an involvement of ASM in generation of ROS 
(Hatanaka et al 1998, Zhang et al 2007). 
Further studies showed that activation and translocation of ASM is dependent on ROS 
generating enzyme NADPH oxidase. NADPH oxidase is one of the primary sources for 
superoxide production (Karupiah et al 2000). A study from Zhang and colleagues clearly 
demonstrated that NADPH oxidase regulates the activity of Asm upon P. aeruginosa 
stimulation in macrophages. P. aeruginosa rapidly activates Asm and ceramide-enriched 
membrane platforms formation while inhibition of NADPH oxidase using 
diphenyleneiodonium chloride (DPI) resulted in blockade of this process (Zhang et al 2008). 
Similar to this finding, the present study showed that irradiation of human glioblastoma cells 
A172 and LN308 leads to rapid activation of ASM which was observed to be ROS dependent. 
However to check if the generated ROS is originated from NADPH oxidase complex further 
studies were carried. To elucidate the mechanism if NADPH oxidase has a role in ASM 
activation, total NADPH oxidase activity was measured upon irradiation in A172 cells which 
showed a 20 % increase in activity. Down regulating of gp91phox using siRNA, one of the 
important subunit of NADPH oxidase in generating superoxide, resulted in the inhibition of 
ASM activation in A172 cells compared with control siRNA transfected cells. However no 
complete block of ASM activation was observed which might be because the gp91phox 
protein was down regulated only around 50 %.  
 
5.3 CLUSTERING OF SIGNALING MOLECULES IN CERAMIDE-ENRICHED 
MEMBRANE PLATFORMS 
In this study clustering of gp91phox in ceramide-enriched membrane platforms/domains was 
demonstrated in human glioblastoma cells A172 and LN308 upon irradiation. The results 
were confirmed by immunofluorescence staining using confocal microscopy. Since surface 
molecules can be easily disrupted if detergents are used during staining process, therefore it is 
very important to avoid detergents during the fixing process. For detecting surface 
localization of gp91phox in ceramide-enriched membrane platforms, antibodies against 
ceramide and gp91phox were used in combination with secondary antibodies. When two 
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different molecules or antigens are needed to be imaged in confocal microscopy sequential 
scanning (from LeicaSP5 software) was performed because it helps to avoid the interference 
of artifacts and crosstalk between various fluorescent channels used. Sequential scanning 
allows detecting multiple fluorophores in one sample by intensifying the image quality and 
avoids crosstalk by recording in a sequential order rather than a synchronal acquisition. 
The role of ceramide-enriched membrane platforms in signaling pathway was fully elucidated 
showing that these platforms trap and cluster death receptors like CD95 and CD40 (Cremesti 
et al 2001, Grassmé et al 2001a, Grassmé et al 2002b). An apoptotic “signalosome” is formed 
as a result of this trapping and clustering of receptors resulting in transmitting and amplifying 
cell death signal inside the cells. Later other signaling molecules like subunits of NADPH 
oxidase particularly gp91phox and p47phox were shown to be clustered in ceramide-enriched 
membrane platforms resulting in activation of ASM in endothelial cells (Bao et al 2010, 
Zhang et al 2007). NADPH oxidase known to be one of the important superoxide radical 
generators was found to be concentrated and activated in lipid raft platforms in endothelial 
cells forming redox lipid rafts (Zhang et al 2006). It was recognized that for formation of 
these redox lipid rafts ASM/ceramide play a crucial role and there exists a feed forward loop 
where ROS produced by NADPH oxidase complex activates ASM in endothelial cells (Zhang 
et al 2007). In endothelial cells, activation of NADPH oxidase within ceramide-enriched 
membrane platforms was shown upon various stress stimuli like Fas-L (Zhang et al 2007), 
endostatin (Jin et al 2008c), TRAIL (Li et al 2013b). Upon irradiation, rat brain microvascular 
endothelial cells showed activation of NADPH oxidase which resulted in production of 
intracellular ROS and increased expression of subunits like Nox4, p22phox, and p47phox. 
Pharmacologic and genetic inhibition of NADPH oxidase was able to block total intracellular 
ROS induced by radiation (Collins-Underwood et al 2008). However it has to be noted that 
the mechanism underlying radiation mediated activation of NADPH oxidase complex has still 
to be elucidated. 
At present the role of ceramide-enriched membrane platforms in activation of NADPH 
oxidase activation remains unanswered. It can be hypothesized that there might be strong 
interactions among the subunits of NADPH oxidase once they are aggregated in ceramide-
enriched membrane platforms thereby enhancing the provocation of ROS. 
 
 
 
5.4 CERAMIDE PRODUCTION  
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Several quantitative methods have been developed for measuring total cellular ceramide like 
high-performance liquid chromatography (HPLC) analysis (Couch et al 1997, Iwamori et al 
1979, Previati et al 1996, Yano et al 1998), high performance thin layer chromatography 
(HPTLC) analysis (Motta et al 1994), evaporative light-scattering detection (McNabb et al 
1999) or using radioactive precursors for labeling of cells (Allan 2000, Tepper and Van 
Blitterswijk 2000). Another widely used technique to measure ceramide is mass spectrometry 
(MS) (Allan 2000, Couch et al 1997, Gu et al 1997, Kalhorn and Zager 1999, Karlsson et al 
1998, Liebisch et al 1999, Mano et al 1997, Watts et al 1999). One of the best used method 
for ceramide quantification is the diacylglycerol (DAG) kinase assay. The advantage of the 
DAG kinase assay over other technique involves the measurement of total mass levels of 
ceramide and the use of crude lipid extracts in the assay. Processing a large number of 
samples in a rapid manner also provides a great advantage of this assay over other standard 
techniques. 
The highly hydrophobic ceramide is extracted in organic solvent from the cells. Cells are 
lysed in a solution containing equal amount of methanol and chloroform. Hydrochloric acid is 
added to the cell lysates for acidification and to extract the shorter acyl chain ceramide-1-
phosphates or hydroxylated ceramides. DAG kinase is one of the fastest ways to measure total 
cellular ceramide, remains to have an advantage over other techniques.  
Ceramide level is known to be increased in various cell lines upon different stress stimuli for 
example with several chemotherapeutic drugs (Grammatikos et al 2007, Lacour et al 2004), 
irradiation (Santana et al 1996), different pathogens (Esen et al 2001, Grassmé et al 1997, 
Grassmé et al 2003b, Jan et al 2000), TNF family of ligands and receptors (Cremesti et al 
2001, Dumitru and Gulbins 2006, Grassmé et al 2001a, Grassmé et al 2001b). However in 
glioma cells ceramide is known to be rapidly consumed by ceramide degrading enzyme 
ceramide glycosyltransferase/glucosylceramide synthase (GCS). It was reported that in 
glioma cells upon gemcitabine treatment failure of ceramide accumulation was observed 
which was found to be the result of ceramide consumption by glycosyltransferase enzyme. 
Pharmacologic or genetic inhibition of this enzyme reversed the event resulting in 
accumulation of ceramide in those cells (Dumitru et al 2009).  
For measuring local ceramide in compartment of human glioblastoma cells, mitochondria 
were isolated before and after irradiation using mitochondrial isolation kit following 
detergent/reagent based method. Various kits are available for isolating mitochondria which 
include reagent based and dounce homogenizer method. Even though the traditional dounce 
homogenization method might help to retain more mitochondrial fraction than compared to 
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reagent based method, the latter method provides an advantage to process several samples 
together. As mentioned in the kit instruction, using reagent based isolation method around six 
samples can be processed at a time in comparison to dounce homogenization method where 
only one samples at a time can be prepared. Once mitochondria were isolated TIMM23 
(mitochondrial marker) was used to confirmed the isolation of mitochondria using western 
blotting. Similarly to check if the isolated fractions are free of contamination different 
organelle markers were used like alpha tubulin for cytoplasm, calnexin for endoplasmic 
reticulum (ER) and Lamp-1 for lysosomes. The fractions isolated were found to be negative 
for markers of cytoplasm and lysosomes but positive for ER marker. This might be because 
various tethering proteins exists that connect ER and mitochondria compartments by 
localizing both sides. One of such proteins is mitofusin 2 which was found to interconnect ER 
and mitochondria during Ca2+ signaling (de Brito and Scorrano 2008). Another protein 
reported for connecting ER and mitochondria is chaperone glucose-regulated protein 75 
(grp75). It was demonstrated that the voltage-dependent anion channel (VDAC) of the outer 
mitochondrial membrane is associated with ER and mitochondrial Ca2+ channels through 
grp75 (Szabadkai et al 2006). 
After isolation of mitochondria from the cells, ceramide DAG kinase assay was performed. 
C16 and C24 ceramide species were separated from other lipids with the use of thin-layer 
chromatography (TLC). Results from scanned TLC plate showed a small increase in ceramide 
in both cell lines. Quantification of TLC was performed using phosphorimager which showed 
a slight increase in ceramide but without statistical significance. As, mentioned earlier 
isolated mitochondrial fractions were found to be contaminated with ER, ceramide is known 
to be synthesized in ER (Stiban et al 2008) and it can be assume that the result from DAG 
kinase assay might show the ceramide synthesized in ER too. As ER synthesized ceramide 
might be equally produced in both irradiated as well as non-irradiated cells. So it could be that 
even if there is a small amount of increase in mitochondrial ceramide in irradiated cells it 
could hardly be seen or no difference in ceramide level could be seen. Another method used 
to measured cellular ceramide was immunofluorescence staining using antibodies against 
ceramide and mitochondria (TIMM23). The result showed an increase in mitochondrial 
ceramide in irradiated cells with no or very less amount of ceramide in non-irradiated cells. 
The settings for laser intensity in confocal microscopy were kept to minimal so that if there is 
a difference in irradiated and non-irradiated cells it could be visualized easily however same 
settings were applied for both irradiated as well as non-irradiated cells. 
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Increase in mitochondrial ceramide was reported before in HeLa cells upon UV irradiation 
(Dai et al 2004) and IR (Lee et al 2011). For identifying the amount of ceramide increased in 
mitochondria Lee and coworkers irradiated cells with 10 Gy and isolated mitochondrial 
ceramide-rich macrodomains (MCRM) using differential centrifugation via a discontinuous 
sucrose gradient. Ceramide was measured using DAG kinase assay 33 h after treated with 
radiation. To confirm the results confocal microscopy was performed to measure cellular 
ceramide using mitotracker red and ceramide antibody (Lee et al 2011). 
 
5.5 INTERACTING PARTNERS OF ASM, CERAMIDE AND LIPID RAFTS 
Previous studies have shown that lysosomal ASM trafficking to plasma membrane is an 
important event resulting in clustering of membrane raft particularly shown by stimulation of 
coronary arterial endothelial cells (CAECs) with Fas ligand (FasL) (Bao et al 2010, Jin et al 
2008b, Shao et al 2003). FasL induced activation of ASM and generation of ceramide further 
leading to lipid raft platforms formation (Zhang et al 2007). These studies showed a direct 
link of ASM with production of ceramide and generation of lipid raft platforms. So our study 
aimed to identify some interacting partners of ASM, ceramide and lipid raft. For this, three 
different experiments were performed namely ASM immunoprecipitation (IP) assay, 
ceramide pull-down assay and lipid raft isolation. For all the three methods the same initial 
step was performed i.e. irradiating cells with 4 Gy or remained untreated followed by lysing 
the cells at 10 and 15 min. IP is one of the best known techniques to precipitate protein of 
interest using specific antibody. Monoclonal or polyclonal antibodies used against the 
particular protein require a solid support like protein A/G PLUS-Agarose beads. Incubating 
with gentle agitation allows the protein of interest to bind with the antibody immobilized on 
the beads. To prove nonspecific binding of proteins, one sample was kept without adding 
antibodies from each particular treatment. Cells were lysed using RIPA buffer. RIPA buffer is 
the most efficient lysis buffer that solubilizes proteins eluding protein degradation and 
resulting in minimal low background effect. Once ASM was precipitated, western blotting 
was used to confirm the IP. It should be noted that IP technique can be troubleshooting 
various times for example non-specific binding of proteins to the beads is one of them. In this 
condition pre-clearing step should be used, this step starts with addition of beads to the cell 
lysates followed by incubation for 30-60 min. This will allow the end result to have lower 
background level and better signal in comparison to noise signal. Another important point that 
needs to be considered during IP is antigen degrading during the process. To avoid this, fresh 
protease inhibitors should be added to buffer for lysing the cells. Beyond these two hindrances 
  
90 DISCUSSION 
many more like incomplete washing, too much antibodies used, too many cells or too much 
protein in lysates can also be problematic. 
Similarly for ceramide pull-down assay, ceramide beads were used and to prove for 
nonspecific binding samples, control beads were included. For lipid raft isolation a method 
was adapted from (Ostrom and Insel 2006) with slight modification. Several ways to prepare 
lipid rafts using detergent or detergent-free methods has been described till date (Schnitzer et 
al 1995, Smart et al 1995, Song et al 1996). To isolate lipid rafts membranes from a variety of 
cells, detergent-free method have been frequently used as the method being more reproducible 
and provides higher inner leaflet-membrane lipids fractions when compared to detergent 
based method (Pike 2004). In this study lipid rafts was isolated using detergent-free method 
using sucrose gradient of 45 %, 35 % and 5 %. On the basis of their density lipid rafts are 
distributed at the interface between the 35 % and 5 % sucrose layer after ultracentrifugation 
for 24 h.  
Three different conditions for the samples were prepared 0 Gy, 4 Gy 10 min and 4 Gy 15 min. 
After samples were prepared from all the three different methods i.e. ASM IP, ceramide pull-
down assay and lipid raft isolation, mass spectrometry (MS) analysis was performed to 
identify the interacting partners of ASM, ceramide and lipid raft. MS remains to be one of the 
best used techniques in the biological research. It can be used for both qualitative and 
quantitative studies. It possesses various advantages like providing information by measuring 
molecular weight accurately, analyzing amino acid, oligonucleotide sequencing and also 
identifies protein structures. However one of the major disadvantages of this technique arises 
when a compound with multiple functional groups has to be analyzed (Ashcroft 2013). 
Various proteins were identified from ASM IP samples; flotillin-1 is one of the proteins 
identified in the samples of 4 Gy 10 min but was not present in non-irradiated samples. 
Flotillin-1 is a subtype of flotillins which are categorized as plasma membrane proteins 
forming detergent-resistant domains known as lipid raft. Besides localizing at plasma 
membrane these proteins are trafficking between different compartments by a so far unknown 
mechanism (Langhorst et al 2008). The role of flotillin-1 has been reported in signaling event 
(Fork et al 2014) and flotillins are also known to interact with various cytoskeletal proteins 
(Affentranger et al 2011, Ludwig et al 2010). Recently it was demonstrated that translocation 
of ASM further leads to its co-localization within flotillin-1 enriched lipid raft (Wei et al 
2013). The findings in this study support our hypothesis that upon IR, ASM is translocated to 
plasma membrane where it gets concentrated in flotillin-1 enriched lipid raft since the protein 
was identified only in the irradiated samples. Similarly various cytoskeletal proteins were 
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identified in the samples after 4 Gy 10 and 15 min including desmocollin-3, f-actin-capping 
protein subunit alpha-2, talin-1. It has been reported that plasma membrane is linked with 
actin cytoskeleton with the involvement of various lipid and proteins (Saarikangas et al 2010, 
Sechi and Wehland 2000). 
From ceramide pull-down assay, at 4 Gy after 10 min samples, only three proteins different 
than 0 Gy were identified namely proliferating cell nuclear antigen (PCNA)-interacting 
partner, elongation factor Tu mitochondrial, low-density lipoprotein receptor-related protein 
5. Ceramide is known to initiate apoptotic signaling process by inhibiting activation of Akt 
with dephosphorylation at Ser473 (Schubert et al 2000). Additionally ceramide is also known 
to lower the expression of PCNA and hindering nuclear import of some important proteins 
like cyclin A resulting in inhibition of cell proliferation (Faustino et al 2008). Similarly it was 
shown that this whole process was regulated by syntaxin 4 (Perrotta et al 2010). Syntaxin 4 
silencing resulted in inhibition of ASM, preventing Akt dephosphorylation finally resulting in 
decrease PCNA thus cells became more proliferative and survived (Perrotta et al 2010). In 4 
Gy, 15 min samples various interesting proteins were identified including caveolin-1. 
Caveolin-1 proteins are one of the forms of caveolae. Caveolae are the vesicles that get 
incorporated in plasma membrane (Severs 1988) and exist in two forms caveolin-1 and 2. 
Caveolin-1 is known to be regulated by lipid raft (Kagawa et al 2015) and is mostly expressed 
on all cells types except most of the tumor cells where it is reported to be absent or down 
regulated (Koleske et al 1995, Lee et al 1998, Racine et al 1999). It is very intriguing that 
caveolin-1 is known to be absent in tumor cells but in our study caveolin-1 was identified in 
malignant tumor cells. Caveolin-1 is known to play an important role in cell growth by 
modulating the activity of various molecules involved in growth factor signaling (Shack et al 
2003). It is correlated to be a tumor suppressor that inactivates several signaling molecules 
involved in survival pathways by interacting with them for example: epidermal growth factor 
receptor (Engelman et al 1998), ERK (Engelman et al 1998, Galbiati et al 1998), 
mitogen/extracellular signal-regulated kinase 1 (Engelman et al 1998, Galbiati et al 1998), 
platelet-derived growth factor receptor (Yamamoto et al 1998), Raf (Engelman et al 1998), 
Src (Li et al 1996). All these finding suggests that caveolin-1 plays important role in 
mediating cell death however this fact remain controversial. In Rat-1 fibroblasts caveolin-1 
resulted in ceramide-induced cell death (Zundel et al 2000) and in LNCaP cells caveolin-1 
was able to suppress c-myc-induced apoptosis (Timme et al 2000). Various Ras related Rab 
and Rap proteins were also identified in 4 Gy, 15 min samples namely Ras-related protein, 
Rab-1A, Rab-1B, Rab-2A, Rab-5C, Rab-6A, Rab-10, Rab 11B, Rab-14, Rab-18, Rab-32 and 
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Rap-1b-like protein. Various Ras proteins are known to be involved in cytoskeletal 
rearrangement (D'Souza-Schorey et al 1997), vesicular trafficking (Conklin et al 2010) and 
signaling pathways (Van Aelst et al 1996). Similarly many cytoskeletal membrane proteins 
like vesicle-associated membrane protein-associated protein B/C, transmembrane protein 109, 
Thy-1 membrane glycoprotein, CD59 glycoprotein were also detected in irradiated samples. 
From the isolated lipid raft caveolin-1 and flotillin 1, 2 were present in both irradiated as well 
as non-irradiated samples. Some reports have suggested that for expression of caveolae, 
flotillin is an important factor. When flotillin-1 was down regulated a decrease of the 
expression of caveolin-1 was observed. This study was performed on endothelial cells where 
association of flotillin-1 and caveolin-1 remained essential for signaling process (Vassilieva et 
al 2009). Apart from membrane proteins various other membrane-associated proteins like 
Ras-related protein Rab-11A, Rab-31, Rab11 family-interacting protein 5, Ras GTPase-
activating protein-binding protein 1, Ras GTPase-activating-like protein IQGAP3, Rho 
GTPase-activating protein 1 was also identified in irradiated samples. Actin cytoskeleton 
plays an important role in maintaining the organization of lipid raft (Simpson-Holley et al 
2002), similarly in this study various cytoskeletal proteins were identified including filamin-
C, F-actin-capping protein subunit alpha-1, F-actin-capping protein subunit alpha-2, twinfilin-
1, dynactin subunit 2, plakophilin-2, profilin-2 in irradiated samples. Apart from flotillin and 
caveolin another protein identified in lipid raft samples before and after irradiation was raftlin 
(raft-linking protein). Raftlin is known to be an essential protein for organizing and 
maintaining the structure of lipid raft and regulates the signal transduction process (Saeki et al 
2003). Two important proteins that were identified in irradiated samples of lipid rafts were 
dysferlin and sortilin which are known to be involved in lysosomal trafficking of ASM to 
plasma membrane. Dysferlin is involved in fusion of lysosomes to plasma membrane through 
its C2A domain (Han et al 2012). Lysosome fusion is one of the most important mechanisms 
resulting in membrane raft clustering. Upon FasL ligand in bovine coronary arterial 
endothelial cells (CAECs) dysferlin was found to be clustered in membrane raft when 
visualized by confocal microscopy however knockdown of this particular protein using 
siRNA prevented the clustering of membrane raft which demonstrated the importance of 
dysferlin in regulating membrane rafts (Han et al 2012). Similarly another important protein 
sortilin was reported to be involved in lysosomal targeting of ASM in the formation of lipid 
raft redox signaling (Jin et al 2008b). Upon FasL stimulation in CAECs, ASM was found to 
be targeted on lysosomal membrane via sortilin which was detected by confocal microscopy 
and fluorescence resonance energy transfer (FRET). FasL stimulated targeting of ASM was 
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abrogated when CAECs were transfected with siRNA of sortilin resulting in deterioration of 
LRs clustering and formation of LR-redox signaling platforms (Jin et al 2008b). 
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6 SUMMARY 
Treating malignant glioblastoma with radiation therapy in combination with chemotherapy is 
one of the most promising outcomes. The present study aimed to elucidate the underlying 
mechanism of IR induced activation of ASM and production of ceramide in glioblastoma. We 
focused on the initial event that involves the activation of ASM and production of ceramide 
upon irradiation in human glioblastoma cells. Irradiation of human glioblastoma cells resulted 
in rapid activation and translocation of ASM to plasma membrane which resulted in clustering 
of ceramide and formation of ceramide-enriched membrane platforms. We addressed the 
mechanism of ASM activation which was found to be dependent on reactive oxygen species 
(ROS) production.  
 
Ceramide enriched-membrane platforms are known to actively cluster signaling molecule 
including death receptors CD95 and CD40 (Cremesti et al 2001, Grassmé et al 2001a, 
Grassmé et al 2001b, Grassmé et al 2002a) or subunits of NADPH oxidase like gp91phox and 
p47phox (Bao et al 2010, Zhang et al 2007). Similar to these observations we found that upon 
irradiation gp91phox clustered in ceramide enriched-membrane platforms and further using 
gp91phox siRNA, inhibition in IR-induced activation of ASM was seen. This result relates to 
the finding from Zhang and colleagues showing NADPH oxidase-derived ROS regulate Asm-
initiated redox signaling in a positive feedback manner (Zhang et al 2008). 
 
Lastly we identified various interacting partners of ASM, ceramide and lipid rafts using LC-
MS/MS technique. Flotillin-1 and caveolin-1 proteins were identified in irradiated samples 
which suggest that upon irradiation, ASM translocated to plasma membrane leads to 
generation of ceramide and further co-localization of ASM and ceramide in lipid raft 
platforms takes place. Various other proteins were identified in irradiated samples of lipid 
rafts including dysferlin and sortilin whose role in ASM trafficking from lysosome to plasma 
membrane has already been described earlier upon different stimuli other than radiation  
(Han et al 2012, Jin et al 2008b).  
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APPENDIX  
 
(Please refer to the CD for the list of proteins obtained from Mass spectrometry analysis, all 
the proteins mentioned in results and discussion parts are highlighted in yellow) 
 
• List of proteins from ASM immunoprecipitation (IP) samples 
• List of proteins from ceramide pull-down assay samples 
• List of proteins from lipid raft samples 
 
MS analysis was performed in the lab from Prof. Dr. Barbara Sitek by Dr. Dominik Megger 
from Clinical Proteomics, Medizinisches Proteom-Center, Zentrum für klinische 
Forschung, Ruhr-Universität Bochum, Germany. 
All the data for MS are the results from two independent experiments 
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